Pharmaceutical historian Vol. 50. 2020, No. 1 by unknown
PHARMACEUTICAL HISTORIAN  ·  2020  ·  Volume 50/1
PHARMACEUTICAL HISTORIAN
An International Journal for the History of Pharmacy
Volume 50 Number 1 – March 2020
Contents
Articles
Pharmacy and migration: James Butler Swann (1834-1901) and his 
three sons in New Zealand, Fiji and Samoa 1862-1936
STUART ANDERSON . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  1
Desperate housewives: Th e rise and fall of the campaign against 
medicated wines in twentieth-century Britain
LORI LOEB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  16 
Short communications 
Th e development of pharmacy education in the Russian Republic 
of Tatarstan, 1755-1975
RUZALIYA TUKHBATULLINA and ALSU KUZNETSOVA  . . . . . . . . . . . . . . . . . . . . . . . . . . .  26
Documents and Sources
Major accessions to repositories in 2018 relating to pharmacy and medicine
THE NATIONAL ARCHIVES, LONDON . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  30
Book Review
Drugs on the Page: Pharmacopoeias and Healing Knowledge in the Early Modern Atlantic World
ANTHONY C. CARTWRIGHT  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  31
https://doi.org/10.24355/dbbs.084-202009111157-0
 PHARMACEUTICAL HISTORIAN  ·  2020  ·  Volume 50/1 1
A R T I C L E
Pharmacy and migration: James Butler 
Swann (1834-1901) and his three sons in 
New Zealand, Fiji and Samoa 1862-1936
Stuart Anderson
Abstract
From the 1850s onwards, substantial numbers of phar-
macists left Britain in search of adventure and fortune. 
One such was James Butler Swann; in 1862 he uprooted 
his family from a settled life in Leicestershire to join a new 
Anglican community in New Zealand. After fi ve years 
the family migrated again to Fiji, attracted by the greater 
prospects of cotton cultivation; but the project failed and 
Swann bought a pharmacy. Over the following years his 
fi rst son established a pharmacy on a neighbouring island, 
his second son established one in Samoa, and his third 
son took over his father’s business on Fiji. Th is article de-
scribes the rapidly shifting social, economic and political 
background against which British migrant pharmacists 
established businesses overseas at this time. 
Introduction
One of the consequences of the rapid expansion of the 
British Empire during the second half of the nineteenth 
century was an increase in the numbers of Britons trav-
elling overseas to run the empire and to serve the needs 
of the ex-patriots and others who did so. Th e growth of 
empire also promoted in at least some of the population 
the desire to travel, the lure of excitement and adven-
ture, and the prospect of making their fortunes. But 
people also migrated for more patriotic or altruistic rea-
sons, to serve their country, to work as missionaries, or 
to be part of shared religious communities. All mi-
grants had to weigh up the ‘pull’ as well as the ‘push’ 
factors before settling on such momentous decisions as 
where to migrate to and when.1 
Th e expansion of empire created a growing demand 
for medical services, and migration embraced a great 
many health care practitioners, including doctors, nurs-
es, and chemists and druggists.2 With the growth of 
expatriate communities around the world, the demand 
for medicines of all kinds vastly expanded, although in 
most places it was also largely unregulated until such 
time as state intervention was deemed necessary. Th e 
opportunities for the sale of medicines, whether coun-
ter prescribed or proprietary, were huge, and along with 
the sale of a wide range of other commodities, many 
pharmacists saw great opportunities not only for adven-
ture but also for personal enrichment.3 
Young British pharmacists were clearly caught up 
in a national mood that encouraged travel abroad, val-
ued overseas experience, and promoted the opportuni-
ties for enrichment. With the start of the British Raj in 
India in 1857 a substantial number headed east, par-
ticularly after the opening of the Suez Canal in 1869, 
which reduced the journey time to three weeks.4 Some 
continued eastwards to Singapore5 and Hong Kong,6 
with some making it as far as China.7 But many of these 
individuals made regular return trips to Great Britain, 
and eventually returned there having made their for-
tunes. 
In addition, substantial numbers migrated to Brit-
ish Dominions including Canada,8 Australia9 and New 
Zealand,10 whilst others headed to South Africa11 and 
to other parts of Africa. Such migrants were much more 
likely to become permanent citizens of the colony or 
territory than those who went to India or south east 
Asia. Still others ventured only as far as Mediterranean 
islands such as Malta and Cyprus, or spent only their 
winters overseas, such as those wintering on the French 
Riviera.12 
In Britain itself, pharmacy was undergoing pro-
found change during this time.13 Th e Pharmaceutical 
Society of Great Britain had been founded in 1841; a 
register of pharmaceutical chemists was established in 
1852, and in 1868 a separate register was created for 
chemists and druggists who had passed the Minor ex-
amination. Th ese rapid changes in the status and qual-
ifi cations of pharmacists roughly coincided with the 
rapid expansion of the British Empire. 
Th ose who left Britain were usually young single 
men in search of adventure and fortune. But there were 
exceptions who made remarkable journeys with young 
families; and only a small proportion of these migrated 
a second or even third time. Th ey included James But-
ler Swann, who took his family from a settled and pros-
perous village life in Leicestershire to a remote area of 
New Zealand. Along with three of his sons, Swann 
came to have an important role in shaping pharmacy 
in both Fiji and Samoa. But what motivated such long-
distance migration? What caused the family to migrate 
a second time? And how did they fare once they arrived 
at their destinations? Th is article explores the reasons 
for the choices they made, and retraces their journeys 
and lives in the South Pacifi c. 
Th e father: James Butler Swann (1834-1901)
James Butler Swann was born on 18 February 1834 in 
the village of Carlton-le-Moorland in Lincolnshire, 
England, to a prosperous local family. His father, who 
was born on 1 October 1798 and also christened James 
Butler Swann, seems to have been a man of independ-
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ent means. His grandfather, John Swann, who had been 
born in Brant Broughton in Lincolnshire in 1752, was 
the vicar in Carlton-le-Moorland, a few miles north of 
Brant Broughton. John Swann and his wife had seven 
children, the second of whom was John Butler Swann. 
John Swann died on 19 January 1827 in Brant 
Broughton aged 75, before James Butler Swann junior, 
his grandson, was born.14
Local records indicate that at the age of 57, in 1855, 
James Butler Swann senior was a well-established local 
land and property owner. Th e Record of Persons Enti-
tled to Vote at an Election in the Parish of Carlton-le-
Moorland indicates that his ‘place of abode’ was 
Heapham, a village in the West Lindsey district of Lin-
colnshire, England, fi ve miles south-east from Gains-
borough. Th e ‘nature of his qualifi cation’ to vote was 
his ‘ownership of freehold and copyhold houses and 
land’; his tenants were listed as ‘William Th eaker and 
others’. But in 1858, at the age of 60, he sold his prop-
erties to the Willoughby family, headed by the Lords 
Middleton of Wollaton Hall, Nottinghamshire, and 
Middleton Hall, Warwickshire. He died on 4 April 
1875 aged 76.15 
James Butler Swann senior and his wife, Anne Clo-
ver (born 3 December 1811), had ten children, and 
James Butler Swann junior was their eldest son.16 After 
serving his apprenticeship in Lincolnshire, probably 
with a local pharmaceutical chemist, he qualifi ed as a 
chemist and druggist around 1855 at the age of 21, hav-
ing completed a fi ve-year apprenticeship. He then went 
into business locally ‘on his own account’,17 moving to 
Bourne in Lincolnshire, about 30 miles south of Carl-
ton-le-Moorland. Th ere he remained for the next seven 
years, where he was described as a ‘prosperous chemist’.18 
At the age of 22 James Butler Swann married Mar-
garet White from Stamford in the south of Lincoln-
shire, on 22 June 1856. Th e couple had eight children: 
the fi rst was Arthur James Swann (born 7 July 1857); 
he was closely followed by William John Swann (born 
3 January 1859), and then by Mary Angela Swann 
(born 25 January 1860), in Bourne. A third son, Joseph 
Ignatius Swann (born 12 February 1861) did not sur-
vive early childhood. Th e couple went on to have four 
more children after migration; two sons in New Zea-
land and two daughters in Fiji.19
Residing at 




James B. Swann head 27 chemist & druggist
Margaret Swann wife 26
Arthur Swann son 3 scholar
William Swann son 2
Mary Swann daughter 1
Joseph Swann son 2m
Robert Kidd apprentice 15 druggist
Henry Swann visitor 16
Esther Paling servant 17 house servant
Rachel Ellis servant 13 nurse maid
Table 1. Th e household of James Butler Swann in 1861 
(Source: 1861 Census for England)
Figure 1. James Butler Swann (1834-1901). (Source: 
Chemist and Druggist. 7 September 1901: 59; 405).
Th e call of New Zealand: Th e Canterbury Associa-
tion
By 1861 James Butler Swann thus had what appeared 
to be a settled and comfortable life; he and his wife em-
ployed two servants, and he had a young apprentice 
druggist who lived with them (Table 1). Yet in 1862, 
with a wife and three young children to support, he set 
off  with his family to Christchurch in the South Island 
of New Zealand to start a new life. Exactly what 
prompted them to make such a momentous move is not 
entirely clear, although tales about the prospects for the 
new colony in New Zealand were circulating in Great 
Britain at the time. 
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Britain had annexed New Zealand following the 
signing of the Treaty of Waitangi on 6 February 1840.20 
In the late 1830s the early British colonists were pressur-
ing the Crown to establish a colony in New Zealand, and 
at the same time a number of Maori leaders were peti-
tioning the British for protection against French forces.21 
Th e fi rst organised group of immigrants arrived in early 
1840, and within a few months a thousand people had 
arrived, forming a settlement that was to become Wel-
lington, at the southern tip of the North Island.22 
Over the next eleven years, between 1840 and 1851, 
ships continued to bring settlers to the new country, with 
new settlements being established at Auckland, New 
Plymouth and Wanganui in the North Island, and Nel-
son, Dunedin and Christchurch on the South Island. 
Christchurch was the main city in the Canterbury re-
gion. In 1852 a New Zealand Constitution Act estab-
lished six provincial governments with settler assemblies; 
three were on the North Island and three on the South 
Island; these were at Canterbury, Nelson and Otogo.23
Th e Swann family were drawn to a small commu-
nity called Kaiapoi located about 17 kilometres north of 
central Christchurch, and close to the mouth of the Wai-
makariri River. Close ties existed between the Church of 
England, this part of New Zealand, and eastern Eng-
land. Christchurch and Lyttleton in the region of Can-
terbury had been founded by Anglican settlers of the 
Canterbury Association twelve years earlier, in 1850.24 
Twelve shiploads of settlers were planned, and the fi rst 
four ships departed in September 1850. Th ere were 773 
colonists, ranging from aristocrats and Oxford graduates, 
to barbers and bricklayers, and shopkeepers and shep-
herds. After the farewell banquet to these ‘Canterbury 
Pilgrims,’ as they became known, a reporter from Th e 
Times wrote that ‘a slice of England, cut from top to bot-
tom, was despatched to the Antipodes’.25
Th e Association had been founded in London in 
March 1848, and was incorporated by Royal Charter in 
November 1849. Th e prime movers were Edward Gibbon 
Wakefi eld (1796-1862) and John Robert Godley (1814-
1861). Wakefi eld was heavily involved in the New Zea-
land Company, which had already established four colo-
nies in New Zealand. He approached Godley to help him 
establish a colony sponsored by the Church of England. 
Th e Archbishop of Canterburv, John Sumner, was 
the President of the Association’s Management Com-
mittee, which also included several other bishops and 
clergy, as well as members of the peerage and Members 
of Parliament. At their fi rst meeting on 27 March 1848 
they decided that the settlement should be called Can-
terbury – after the Archbishop of Canterbury – and the 
seat of the settlement should be called Christchurch, 
after the Oxford College at which Godley had studied.
Th e Canterbury Association implemented the sys-
tematic colonisation ideas of Edward Wakefi eld. Sheep 
farming on Canterbury Plains, and later wheat, became 
economic mainstays, and Christchurch and Canter-
bury Province prospered.26 Th e Association refl ected 
Godley’s ecclesiastical and political infl uence, and he 
– like Wakefi eld – distinguished sharply between colo-
nisation and mere emigration. Canterbury was to have 
settlers of wealth and position, as well as assisted mi-
grants, a balance of the sexes, and churches and schools 
from the outset. Its purpose was to plant overseas a so-
ciety which would carry on the values of an England 
increasingly threatened by industrialisation and revolu-
tion at home. Th e prospect of a new life and greater 
prosperity in a Church of England community in New 
Zealand was clearly very attractive to James Butler 
Swann and his family.
Th e Association’s plan was to purchase 300,000 acres 
of land for settlement by members of the Church of Eng-
land, selected from all ranks of society and supported by 
religious and educational endowments.27 One of the 
Figure 2. Emigration for the Working Classes, 1862. 
(Source: http://gallery.archives.govt.nz/v/christchurch/
Early+ships/images/19XX_2_952_Emigration+poster.jpg.
html. Accessed 28 July 2019)
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founding members of the Canterbury Association, who 
attended its fi rst meeting, was Sir Charles Bowyer Adder-
ley, the fi rst Baron Norton. He was born in 1814 at Knigh-
ton House in Leicestershire, and, like Godley, attended 
Christ Church Oxford. Sir Charles bought a number of 
plots of land in New Zealand, including 100 acres in 
Christchurch town, and – more signifi cantly – 150 acres 
at Kaiapoi. For this purchase Godley was his agent.28 
Th e journey to New Zealand
Cash-strapped provincial councils on New Zealand’s 
South Island worked very hard to recruit migrants in 
the 1850s and 1860s, but only Canterbury and Otago 
succeeded.29 In the mid-nineteenth century the Kaiapoi 
area became a centre for the rapidly expanding wool 
export business. To encourage settlement in New Zea-
land the Government provided funding for an assisted 
passenger scheme (Figure 2). Th e Canterbury Associa-
tion would ‘grant assisted passages to a limited number 
of the working classes,’ including shepherds, farm serv-
ants and labourers. Applicants ‘must be of highest char-
acter’ and ‘certifi ed by the clergyman of their Parish’. 
James Butler Swann and his family travelled under 
this scheme on board the migrant ship Queen of the 
Mersey. Th is was an American ship that had been built 
in 1860 for Mr. H. Melvain, of Newcastle. In 1862 she 
was chartered for two voyages to New Zealand. On 3 
July 1862 she sailed from London for Lyttelton, a port 
on the north shore of Lyttelton Harbour close to Christ-
church, on the eastern coast of the South Island. Due 
to its establishment as a landing point for Christchurch-
bound seafarers, Lyttelton was regarded as the ‘Gate-
way to Canterbury’ for colonial settlers.30 
On that journey the Queen of the Mersey carried with 
her 349 Government immigrants under Captain Aitkin; 
the passengers listed included James Butler Swann (29), 
Margaret Swann (28), Arthur Swann (5), William 
Swann (3) and Mary Swann (2).31 James Butler Swann 
was listed as a ‘farm labourer’ from Lincolnshire. Th is 
may have been because Swann registered as such under 
the assisted passenger scheme, although it was a not in-
frequent mis-recording of pharmacist (‘farm assist’). 
It was a long and eventful journey round the south-
ern tip of Africa. Ten deaths occurred – mostly children 
from measles – although this was rather less than some 
emigrant ships. On some ships burials at sea almost be-
came routine.32 During the passage a serious mutiny 
took place among some of the crew, who attempted to 
broach cargo and get at the spirits. After the men had 
been placed in irons Captain Aitkin was violently as-
saulted and struck by one of the sailors. On arrival fi ve 
of the men were arrested and sentenced to a term of im-
prisonment.33
Arrival in Kaiapoi
Th e Queen of the Mersey arrived at Lyttelton on 19 Oc-
tober 1862, having made the passage in 108 days.34 It is 
likely that the family would have been well prepared 
about what to expect when they arrived. As well as sup-
port from the Church of England they would have re-
ceived much practical help from one or more of the guide 
books available at the time for intending migrants. Th ese 
included Cooper’s Th e New Zealand Settlers’ Guide of 
1857; Earp’s 1848 Th e Emigrants’ Guide to New Zealand, 
and Earp’s Handbook for intending emigrants to the south-
ern settlements of New Zealand of 1856. 35
Th e Swann family arrived during the peak of migra-
tion to New Zealand. Between 1858 and 1860 20,831 
arrived there; between 1861 and 1865 the fi gure was 
93,169 (the family arrived in 1862); and between 1866 
and 1870 it reduced again, to 20,536.36 Overall, New 
Zealand’s European population grew from 5,000 in 
1841 to well over 600,000 in 1891.37 Th e number settled 
in the Canterbury region were just 3,273 in 1851, but it 
had increased to 16,090 in 1861 and to 46,934 in 1871.38
Th e family appear to have proceeded immediately 
to Kaiapoi (Figure 3) and James Butler Swann wasted 
no time in setting up in business as a chemist and cor-
dial-manufacturer.39 An immigrant pharmacist would 
have needed to have both considerable capital and to 
take everything he would need for his business with 
him. Coombes has suggested that this would include 
all his stock, plants and fi ttings: 
Bottles, corks, boxes, wrapping and note paper, la-
bels, account forms, scales, glass measures, pill ma-
chines, plaster irons, marble slabs for preparing oint-
ment, shop fi ttings, leaves, roots, rhizomes, plus 
household and personal needs, all had to be assem-
bled and carefully packed for a journey of over 
12,000 miles by sailing ship.40 
Figure 3. Location of Kaiapoi, New Zealand. (Source: 
https://www.weather-forecast.com/locationmaps/Kaiapoi.
8.gif. Accessed 28 July 2019)
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Swann no doubt expected to be serving the needs 
of a prosperous and expanding community.41 Th e most 
lucrative businesses in the area in the 1860s and 1870s 
were the raising of livestock and expanding its fi nanc-
ing.42 During the 1860s the colony’s two main activities 
were wool and goldmining, although for a while sup-
plying the British troops was a rewarding activity. Be-
tween 1861 and 1870 the number of sheep rose three 
and a half times, with wool exports expanding fi ve 
times. In Canterbury the political and economic infl u-
ence of those who owned or leased sheep farms, al-
though probably numbering fewer than 1,000, was un-
rivalled. Initially, sheep farming provided seasonal jobs 
in wool stores, with money coming into the local econ-
omy. Flax was also an important commodity locally. It 
had been an important product since Cook and Banks 
pointed out that its fi bre was useful for the making of 
ropes and cordage.43 Th e value of fl ax exports reached 
a peak in 1831, after which it declined sharply, showing 
some recovery in 1834, 1836 and 1839.44 By the 1860s 
it was processed commercially in only a few local com-
munities; but in Kaiapoi a fl ax mill was opened in 
1866, although it was soon converted for the processing 
of wool.45 
Th e family stayed in the area for fi ve years, until the 
summer of 1867. James and his wife Margaret had two 
more sons whilst in New Zealand: Frederick Swann, 
who was born in Kaiapoi on 10 October 1864, and 
Herbert Charles Swann, born on 14 May 1867 in 
Christchurch.46
Pharmacy practice in Kaiapoi
Swann’s pharmacy business is likely to have been the 
only one in the town. According to his granddaughter’s 
biographer the business thrived.47 But Swann was by no 
means the fi rst pharmacist to arrive in the Canterbury 
region. Th at honour fell to Arthur Bayfi eld, who had 
arrived aboard the SS Randolph in December 1850 with 
the fi rst pilgrims to Canterbury, along with ‘a young 
wife, one son and suffi  cient stock to open a pharmacy’.48 
He established a business in Canterbury Street, Lyttel-
ton, and took an active part in community service. Like 
Swann ten years later, isolation probably limited his 
contact with other pharmacists, as neither of their 
names appear in offi  cial pharmacy records at the time. 
But Bayfi eld became an active volunteer fi reman, a ves-
tryman of the Anglican Church, a member of the Col-
onists’ Society, and sub-postmaster to Lyttelton.49 Re-
tail pharmacy for pioneer migrants was a very diverse 
activity. A wide range of non-pharmacy products was 
usually necessary for survival. Diff erent pharmacies ad-
vertised ‘paints, oils, white lead, pickles, stationery, 
spices and curry powder, as well as tonics, blood puri-
fi ers, mixtures and packaged pills as treatment for ail-
ments ranging from corns to dandruff ’.50 Remedies 
were often quoted to be to ‘our own formula’. Patent 
medicines had to be imported and were sold at low prof-
it margins, and pharmacists prepared, packed and pro-
moted their own proprietaries wherever possible.
With medical doctors, dentists, opticians and vet-
erinarians all being far fewer in number than chemists 
and druggists, these early pharmacists had to turn their 
hands to many other skills. Th ese often included ex-
tracting teeth and sight testing, as well as providing 
care and treatment to cows, horses, pigs, poultry and 
sheep. Th e rising number of settlers needed roads, rail-
ways, houses and work, and labourers, craftsmen and 
tradesmen followed the road and rail construction. As 
small towns developed pharmacists moved in to serve 
them. Th e hours were long and the facilities few, but – 
it is claimed – the pioneer pharmacists rarely failed to 
get required medicines in emergencies.51 During the 
1860s and 1870s pharmacy businesses in New Zealand 
slowly became more secure. Shop fi ttings and appear-
ance improved, and pharmacists increasingly made use 
of imported fi ttings, carboys and shop bottles. Th e ser-
vices on off er gradually became more professional. But 
initially there was no professional authority regulating 
the practice of pharmacy. Not until 1878 did 27 chem-
ists (nearly all those then in Canterbury) meet to agree 
to form a Pharmaceutical Society of New Zealand.52 
But James Butler Swann had left New Zealand for Fiji 
13 years earlier, in 1867. 
Tensions in New Zealand 1862-1867
What it was that fi nally persuaded Swann to uproot his 
family for a second time is not entirely clear. As with 
the initial move, it was most probably a combination of 
‘pull’ and ‘push’ factors, both economic and political. 
In a small town so far from the main town of Christ-
church the business may not have been as successful as 
he had hoped. Politically there were still rumblings 
from arguments over the Treaty of Waitangi in 1840, 
which had provided only a short-term peace. Tensions 
grew over disputed land purchases, resulting in a series 
of confl icts between the British settlers of New Zealand 
and various Maori opponents. Th ese continued for over 
27 years, and were known as the New Zealand or Mao-
ri Wars.53 
Although the wars were initially localized con-
fl icts, they escalated dramatically from 1860 as the 
government became convinced that it was facing unit-
ed Maori resistance to further land sales and a refusal 
to acknowledge Crown sovereignty. Th e colonial gov-
ernment summoned thousands of British troops to 
mount major campaigns to overpower the Maori 
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King, and to acquire farming and residential land for 
British settlers. At the peak of hostilities in the 1860s, 
18,000 British troops battled about 4,000 Maori war-
riors in what became a gross imbalance of manpower 
and weaponry.54
Swann and his family would have been only too 
aware of these worrying developments. A telegraph ca-
ble was laid between the North and South Islands in 
1866.55 Th ey would have become increasingly con-
cerned for their own safety and security, especially 
when all but one regiment of imperial troops were with-
drawn from New Zealand in 1865-66.56 Th ey would 
also have received news from across the South Pacifi c 
area, which was developing rapidly, particularly on the 
islands of Fiji, Samoa and Tonga. 
Th e prospects off ered by Fiji as an emerging colony, 
particularly with the rapid development of cotton plan-
tations, and the opportunity to make substantial prof-
its for those who got in at the beginning, must have 
been very strong pull factors for James Butler Swann. 
For he was to be caught up in the ‘Fiji cotton boom’ of 
the 1860s.57 Th e family arrived there in 1867. 
In 1835 two missionaries from the Wesleyan Lon-
don Missionary Society arrived on Lakeba in Lau and 
established the fi rst mission in Fiji. Other missionaries 
followed, setting up a base around Levuka, originally a 
whaling settlement where European merchants had es-
tablished a small trading outpost. Levuka is located on 
the eastern coast of the lush volcanic island of Ovalau, 
a smaller island to the east of one of the two larger is-
lands, Viti Levu, and is separated from it by a 20 kilo-
metre-wide channel. (Figure 4). 
It was a challenging place. In 1840 Charles Wilkes 
had led a US expedition that produced the fi rst com-
plete chart of the Fijian Islands. He signed a treaty with 
the local chief, Cakabau, in which the local people were 
paid for the protection of foreign ships and the supply 
of provisions.59 But relations deteriorated, and in 1841 
Levuka was razed by fi res, which the settlers suspected 
Cakabau of instigating. In 1849 the home of the US 
consul was destroyed by fi re, and the locals helped 
themselves to his possessions. Th e consul held Cakabau 
responsible and sent him a substantial damages bill. Th e 
dispute was to have major repercussions for the future 
of Fiji. 
Disruption to supplies of American cotton during 
the Civil War between 1861 and 1865 resulted in high 
cotton prices in Europe, and encouraged its production 
in many other parts of the world, including some of the 
South Pacifi c islands, and Fiji in particular. Th e prom-
ise of cheap land, cheap labour and large profi ts from 
growing tropical products drew many Europeans to the 
Fiji group of islands, where they would be less shackled 
by constraints imposed by government, law and taxa-
tion. 
Swann would have heard about the opportunities 
in Fiji whilst in New Zealand. Enthusiastic but exag-
gerated reports appeared in both the Australian and 
New Zealand press about the opportunities available, 
and they also appeared in various promotional publica-
tions. Typical was an editorial which appeared in Th e 
Herald of Melbourne in 1868: 
To the small capitalists, the men prepared to en-
counter danger and privation, Fiji presents a brilliant 
future. Hundreds of young men in Europe and in 
this community are now eagerly looking for some 
such opening as Victoria and the neighbouring col-
onies presented twenty years ago.
Whilst the possible benefi ts were played up – with 
claims such as that the planter could expect returns 
within two years – the diffi  culties were played down. 
Th us, in a pamphlet authored by ‘Ceres’ in 1869 the 
labour problem was passed over with the assertion that 
Figure 4. Map of Fiji. (Source: http://pergoladach.co/fi ji-
islands-map. Accessed 28 July 2019)
Th e lure of Fiji
By the 1860s Europeans were to be found on most of 
the major island groups in the South Pacifi c. Th e French 
were already established in New Caledonia and Tahiti 
and the Germans in Samoa. It is thought that the fi rst 
white people to land on Fijian soil were the crew of the 
schooner Argo, which had been shipwrecked off  Onea-
ta in Lau at the south west corner of the Fijian islands 
in 1800. Th ereafter a steady stream of merchant ships 
from Sydney Harbour began to arrive, attracted by the 
newly discovered sandalwood at Bua Bay on Vanua 
Levu.58 
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‘labourers could easily be imported from the adjacent 
islands to the Fiji group under three-year contracts’. 
Likewise, the diffi  culty of obtaining land from Fijian 
land owners was played down. 
illusory. Th e diffi  culties entailed in buying suffi  cient 
good quality land and of obtaining enough reliable la-
bour would have soon eaten through his remaining cap-
ital. 
Swann soon recognised the reality of the situation 
in which he had placed his family. Fortunately, he had 
a back-up plan. Within three years of his arrival in Fiji, 
in 1870, he bought the old chemist’s business of Dr Ri-
ley in Levuka.64 He remained there for the next twenty-
four years, and he and his wife had two more children 
in Fiji; Margaret Teresa Swann was born on 20 March 
1872, and Agnes Elanor Swann followed on 7 Septem-
ber 1873.65
In Levuka on Ovalau island he slowly built up the 
business, until 1894, when he had a paralytic seizure. 
Th e seizure led to his retirement at the age of 60, which 
was lived in Fiji, between 1894 and 1901. James Butler 
Swann died on 19 May 1901 in Levuka, Fiji, at the age 
of 67 years.66
Figure 5. View of Levuka, Fiji, 1870s. (Source: https://
levuka.wordpress.com. Accessed 28 July 2019)
Th e move to Fiji 
James Butler Swann was clearly persuaded by the slick 
advertising, and as a result the enlarged Swann family 
took the momentous decision to move again, to make 
a second migratory move northwards. Th ey arrived in 
Fiji on 4 July 1867 on board the schooner William and 
Mary.60 Th ey sailed into Levuka on Ovalau island, 
which was then the capital of Fiji (Figure 5). From there 
they crossed the short channel to the main island of Viti 
Levu, where James Butler Swann became a cotton-
planter. He ‘experimented’ with cotton planting at Nai-
korokora on the banks of the River Rewa.61 
It seems that the Swann family was among the ear-
lier group of settlers, with the rush slowing building 
from the early 1860s. One witness recorded that ‘every 
week parties of ten or twenty were arriving from the 
Australian colonies in search of sheep lands or from 
New Zealand in search of any place where they could 
escape the ravages of the Maori war’.62 
Th is witness noted that in 1864 there were about 
300 Europeans in the group, but by 1867 there were 
411 British, 38 Americans, and 43 other Europeans, 
mainly Germans, making a total of 492, plus a half-
caste population of 339. By the following year, 1868, 
the total number of Europeans had almost doubled to 
862, a fi gure made up of 583 men, 93 women and 186 
children, but did not include 386 half-castes. Th e ma-
jority of the newcomers were ‘British settlers and their 
families from New Zealand’.63 Th is number almost cer-
tainly included Swann, his wife, four sons and a daugh-
ter. 
By 1869 cotton had become the almost exclusive 
crop produced in Fiji. But it is clear that Swann’s ven-
ture as a cotton planter was not a success. Th e prom-
ises of cheap land, cheap labour and large profi ts were 
Figure 6. Arthur James Swann (1857-1926). (Source: 
https://www.geni.com/people/Arthur/600000001761
8349431. Accessed 28 July 2019)
Th e fi rst son: Arthur James Swann (1857-1926): A 
second Fiji pharmacy 
James Butler Swann’s eldest son, Arthur James Swann, 
had been born in Bourne, Lincolnshire, on 7 July 1857. 
He had moved with his family to New Zealand at the 
age of fi ve, and from New Zealand to Fiji in 1867 at the 
age of ten. His education began in New Zealand, and 
he later went to school in Levuka, Fiji and Sydney, Aus-
tralia, as did his younger brothers. 
Arthur James Swann later qualifi ed as a pharmacist; 
there was no pharmacy college in Fiji, and in New Zea-
land pharmacy was only formally recognised with the 
Pharmacy Act in 1880. It seems most likely that Arthur 
was apprenticed to his own father at the pharmacy at 
Levuka for four or fi ve years.67 We know that his young-
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er brother William was sent to England to study chem-
istry, and it seems highly probable that all three older 
brothers went to study at one of the London crammer 
schools of pharmacy before taking the Minor examina-
tion of the Pharmaceutical Society of Great Britain. 
Arthur James Swann qualifi ed as a chemist and drug-
gist around 1878.
Arthur probably returned initially to his father’s shop 
in Levuka, although within a few short years he moved 
to Suva on Fiji’s main island of Viti Levu. Levuka at that 
time may not have been large enough to provide a living 
for two pharmacies, and there is some evidence that 
Swann was not the only British pharmacist to set up a 
pharmacy business in Levuka. Th omas Parker was born 
in Ireland c.1837 and had emigrated fi rst to Melbourne, 
in Australia on the Bloomer in 1854. Th omas appears to 
have established a business as a chemist and druggist in 
Queensland in Australia in 1877, before also emigrating 
again to Fiji. He is recorded as working as a chemist in 
Levuka in 1873 and 1874.68 James Butler Swann had 
opened his pharmacy in Levuka in 1870. 
It is however more than likely that Arthur was re-
sponding to international political events. For after be-
ing held accountable for the impossible debt to the 
United States in 1849 the local chief appealed to the 
British consul in Levuka for help, promising the sover-
eignty of Fiji to Britain along with thousands of acres 
of land if the debt was paid off . However, cession was 
initially rejected by Britain in 1862, on the grounds 
that the chief did not represent all the peoples of Fiji 
and that the profi tability of the colony was not assured. 
Th e debt was not paid. 
Th e chief turned to the newly formed Australian Poly-
nesia Company, which guaranteed payment of the 
claim in return for land around Suva on Viti Levu is-
land (Figure 7). In 1871, the local king, Cakobau, de-
clared the formation of a government in Levuka. Reg-
ulations mainly concerned with the sale of land, alcohol 
and fi rearms were laid down, and a poll and land tax 
was introduced. 
Th ese changes were badly received, and riots broke 
out. Local Fijians, unable to pay the land tax, were co-
erced into working on the plantations. Within two 
years, Cakabau had lost the trust of his people, divided 
the Levuka traders, and run up massive debts. He once 
again off ered to cede Fiji to Britain, and this time it was 
accepted. On 10 October 1874, in a pompous ceremo-
ny in Levuka, Cakobau and the other chiefs signed the 
deed ceding sovereignty to Britain.
But before long the colonial capital of Levuka be-
gan to run out of land to expand. Two Melbourne 
merchants, Th omson and Renwick, encouraged the 
government to relocate the capital from Levuka on 
Ovalau to Suva on Viti Levu with incentives in the 
form of land grants. Th e government offi  cially moved 
to Suva in 1882, when it was a township of about a 
dozen buildings. By the 1920s it had become a fl our-
ishing colonial centre, and it was offi  cially declared a 
city.
Figure 7. View of Suva, Fiji, 1880s. (Source: http://www.
justpacifi c.com/fi ji/fi jiphotos/cards/towns/index.html. Ac-
cessed 28 July 2019)
Figure 8. Suva, Fiji, 1920s. Swann & Co. pharmacy at 
centre. (Source: Rose Series of De Luxe postcards, Rose Ste-
reographs, Victoria, Australia. Accessed 28 July 2019)
Arthur James Swann made the move from Levuka on 
Ovalau to Suva on Viti Levu soon after. He founded 
his pharmacy there in 1883, and slowly built up the 
business over the next 43 years, until his death (Figure 
8). Th e business survives to this day as A. J. Swann 
Pharmacy Ltd, and is located at MH Rodwell Rd Com-
plex Suva, Fiji. Arthur James Swann died on 6 Septem-
ber 1926 in Suva, Fiji, at the age of 69 years. 
But the Americans continued to pursue their claim, and 
in 1867 – the year Swann and his family moved to Fiji 
– an American warship threatened to bombard Levuka. 
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ister of the Pharmaceutical Society received their edu-
cation and passed their examinations from the West-
minster College of Chemistry and Pharmacy’.71 
Th e names of over 800 of these are listed in the pub-
lication, although they do not include the names of any 
of the Swann brothers. Th e archives of the Society’s 
own school of pharmacy in Bloomsbury also give no 
hint of attendance by the Swann Brothers. Wills is how-
ever keen to emphasise that his students came from 
across the world:
Not all the College men have settled, however, in the 
British Isles. Th ey are to be found in every part of the 
Globe, and, as the Irishman said, ‘elsewhere’. Mr Wills 
is now in regular correspondence with old pupils who 
live in Paris, Gibraltar, Malta, New York, Shanghai, 
Hong Kong, Adelaide, Melbourne, Sydney, Gladstone, 
Brisbane, Tasmania, Natal, Kimberley, Bulawayo, 
Johannesburg, Cairo, Bangalore and Old Calabar.72
According to his daughter, William was an outstand-
ing pupil in his class, but he was apparently tormented 
by acute homesickness.73 He was anxious to complete 
his course as quickly as possible, and to return to his 
family in Fiji. On his return William worked for some 
time in the family shop in Levuka. Whilst there he 
learnt what he could about medicine so as to become 
familiar with the best possible treatments for many 
tropical diseases, about which little was known at the 
time. 
Despite his homesickness whilst in England Wil-
liam soon became restless again. He hoped that his new 
knowledge would provide him with opportunities to 
explore more of the South Seas. In the mid-1880s his 
eff orts were rewarded when he was off ered the post of 
apothecary on the ship US Mohican, an American Navy 
Figure 9. William John Swann (1859-1936). (Source: 
Eustis, N. (Note 17) 1979: 48)
Th e second son: William John Swann (1859-1936): 
A new start in Samoa 
James Butler Swann’s second son, William John Swann, 
was born on 3 January 1859, in Bourne, Lincolnshire. 
He was three and a half years old when the family mi-
grated to New Zealand, and only eight when they 
moved to Fiji. His early education took place in New 
Zealand and continued in Fiji when the family settled 
there. We know that, at the age of 17 in 1876, his father 
sent him to England to study chemistry.69 It seems like-
ly that he attended one of the colleges of chemistry and 
pharmacy that had been established in London, prob-
ably either John Muter’s South London School of 
Chemistry and Pharmacy (opened in 1872) or George 
Wills’ Westminster College of Chemistry and Pharma-
cy (opened in 1874).70 
Th ese colleges off ered short cramming courses to 
prepare candidates for the Minor examination of the 
Pharmaceutical Society of Great Britain. Large num-
bers of students attended them. Wills published a jubi-
lee souvenir of the College in 1899, in which he states 
that ‘nearly 4,000 chemists and druggists on the Reg-
Figure 10. USS Mohican, 1894. (Source: http://www.
navsource.org/archives/09/46/46909.htm. Accessed 17 No-
vember 2019)
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vessel that weaved a leisurely course through the is-
lands, dropping anchor at the more important trading 
ports of the South Seas (Figure 10). During this time 
he acquired great profi ciency in dealing with the native 
peoples of the Pacifi c.74 
ert Louis Stevenson was sailing his schooner Equator 
through the South Seas in search of a climate suitable 
for his tubercular condition. In December 1889 the 
Stevenson family landed in Apia and initially rented 
a small house. Th ey eventually settled there in Sep-
tember 1890.
Stevenson was always keen to hear of any new drug 
discoveries that might help his condition, and not sur-
prisingly he became a regular visitor to the Swann phar-
macy. Stevenson and Swann soon became close friends. 
Stevenson built a home on a prominent 150-acre plot, 
and Swann became a frequent visitor, often treating the 
family for prevailing tropical complaints.
William’s wife and children
With his business fl ourishing, William found time to 
look for a wife. He became friendly with a beautiful 20-
year old local girl called Pele from Toamua village. Her 
father was the chief of Toamua village, and her mother 
was a daughter of a high chief of Apia village. In 1891 
William Swann and Pele were married in a Roman 
Catholic service in Apia conducted by a European 
priest.76 Amongst the guests at the wedding was Robert 
Louis Stevenson. 
William and Pele went on to have three daughters 
and a son. Th e fi rst was Margaret (Maggie) Swann, 
born in 1893 at their home above the chemist’s shop in 
Beach Road. She was followed four years later by Agnes 
(Aggie) Swann, in 1897; by Violet Swann in 1899, and 
Figure 11. Map of Samoa. (Source: https://www.pinterest.
co.uk/pin/396598310905345464. Accessed 28 July 2019)
Setting up in business in Samoa 1889
After a few years as a ship’s apothecary William appar-
ently grew tired of life at sea, and searched South Sea 
ports for an opportunity to open up his own chemist’s 
shop. He hoped to open a small dispensary far away 
from any strong competition. As in Fiji, international 
politics played an important part in his decisions. In 
the 1870s there had been considerable rivalry between 
Great Britain, German and the United States as to who 
should be the ruling power in Samoa (Figure 11). 
In 1877 a group of Samoans visited Fiji asking for 
British protection, but this was refused. In 1878 they 
went to the United States again requesting protection, 
but this too was refused. Eventually in 1885 the British 
High Commissioner proclaimed the Municipality of 
Apia in western Samoa to be an international settle-
ment. William set up his pharmacy business in Apia at 
the start of 1889, at the age of 30 (Figure 12). 
Within a few weeks of opening, on 15 March 
1889, a devastating hurricane swept down on Samoa.75 
Th is wreaked hovoc on the ships of the three navies 
sheltering in Apia harbour. Th e three powers gathered 
to sign the 1889 Berlin Treaty, which called for an in-
dependent Samoa, with an Apia Governing Board in 
authority in the township area. However, the peace 
did not last long, and fi ghting erupted sporadically 
throughout Samoa. 
William was undaunted by the disturbances 
around him; his business occupied a prominent posi-
tion in Beach Road. Around this time, the writer Rob-
Figure 12. Swann Pharmacy, Apia, Samoa, 1880s. 
(Source: Eustis, N. (Note 17) 1979: 49)
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fi nally by William (Willie) Swann, born in October 
1902. But just three months later, in January 1903, Pele 
died at the age of 31. She was buried at the Catholic 
Marist Brothers cemetery at Savalalo in Apia.77 
Th e three girls were destined to become famous as 
the ‘Swann bouquet’, the toast of Apia town,78 but by 
far the most famous was Aggie. Aggie Grey, as she be-
came, founded a hotel in 1933 and hosted many famous 
actors. Th e American writer James Michener was a 
friend, and he is widely believed to have modeled his 
character Bloody Mary in Tales of the South Pacifi c 
(1947) on Aggie. Th e book was subsequently adapted 
into the Rogers and Hammerstein 1949 fi lm South Pa-
cifi c.79 Aggie was a pioneering fi gure of the Samoan ho-
tel industry and appeared on several postage stamps. 
She became one of Samoa’s most well-known fi gures, 
and died on 26 June 1988 aged 90.
Pharmacy in Apia, Samoa, 1889 to 1936
William was left to bring up his three daughters on his 
own. With a young family and a growing business to 
look after he had little free time. As well as being a 
pharmacist, he acted as a doctor to the Samoans, and 
also as a dentist, reportedly extracting teeth with con-
siderable skill.80 
Th e South Sea islands again became the stage for in-
ternational events. In 1899, whilst Britain was engaged 
in the Boer War, Germany demanded that the 1889 Ber-
lin Treaty be scrapped. As a result, Germany was given 
the right to annex Western Samoa, and the United States 
was permitted to control Eastern Samoa. Th e news 
reached Apia from Europe in November 1899. Th e Ger-
man Empire then made its presence felt, and one of its 
most important outposts was Apia in Samoa. 
Th e German Era in Samoa lasted from 1899 to 
1914. During the early years of the occupation the 
Swann family business prospered, as more traders 
brought about a controlled economy previously un-
known in Samoa.81 Th e Swann pharmacy and home 
was located next door to the British Club.82 Th e Inter-
national Hotel was situated directly opposite and pro-
vided a major boost to business. Th e hotel advertised 
saltwater bathing and freshwater showers, and off ered 
billiards, bagatelle, and commodious sample rooms for 
travellers.83 
Swann nevertheless soon found himself with stiff  
competition. With the German occupation a German 
chemist, G. Sabiel, who was in business nearby in 
Beach Road, proposed to run Swann out of Apia. He 
approached the Customs Department for special privi-
leges as a German national. But R.P. Berking, the Ger-
man-born Collector of Customs from 1905 until 1914, 
would not agree to Sabiel’s proposals, ruling that Swann 
already had his business established in Samoa ‘where 
everyone has the same rights’.84 
With the outbreak of war in 1914 the Germans de-
parted and were replaced by New Zealanders. Th e New 
Zealand occupation favoured British traders and plant-
ers, and Swann secured several lucrative contracts with 
the army, supplying them with remedies that were un-
available in the troops’ dispensaries.85 Towards the end 
of 1914 the Union Steamship Company of New Zea-
land, which had long provided the only regular service 
to Western Samoa, opened a branch in Apia.86
A severe earthquake struck Samoa on 26 June 1917, 
with the fi rst eff ects felt at 6.23pm.87 Considerable 
damage was caused. In its report the Samoa Times re-
corded that:
Mr Swann the chemist also had considerable losses 
to report. An inspection of his premises after the 
dread occurrence revealed the shop fl oor strewn with 
broken bottles, powdered drugs, lozenges and liq-
uids, the pungent odour of iodine being particular-
ly noticeable.88
After the war William settled into life as the local phar-
macist. He remarried another local girl called Fa’afeti 
from Apia village, and they went on to have two chil-
Figure 13. Frederick Swann (1864-1924). (Source: Cyclo-
pedia of Fiji Illustrated. (Note 59) 1907: 267)
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dren of their own, Fred and Daisy.89 He twice met Eng-
lish royalty; fi rst in 1880 when he acted as interpreter 
for the visit to Fiji of the Duke of Clarence and Prince 
George (later King George V); and again in 1920 when 
he met the Prince of Wales (later King Edward VIII) 
during his tour of Western Samoa.90 
William John Swann died on 20 May 1936 at the 
Government Hospital in Apia91 in Samoa at the age 
of 77.92 Amongst those present at the funeral were his 
only remaining brothers and sisters; Herbert Swann 
of Levuka, Fiji, Mrs H.P. St Julian of Sydney, and 
Sister Mary Joseph of the Marist Sisters Convent at 
Levuka.93
Th e third son: Frederick Swann (1864-1924)
James Butler Swann’s second youngest son, Frederick, 
was born in Kaiapoi, near Christchurch on New Zea-
land’s South Island on 10 October 1864. He arrived in 
Levuka on Fiji with his family on 4 July 1867 aged 2¾. 
He was educated fi rst by a governess and later at Mr 
Ewin’s School in Levuka (the fi rst public school in Lev-
uka was founded only in 1879). In his early teens he 
went to Sydney, New South Wales, to continue his ed-
ucation.94 He attended fi rst Newtown Academy (Mr 
Sampson’s) in Sydney, and then a fi nishing school, the 
Fort Street High School in Sydney (Figure 14) which 
had been established in 1849, before returning to Fiji. 
sistant dispenser at Levuka Hospital (Figure 15). After 
a few months he became dispenser, and remained in 
service there for fi ve years. 
Figure 14. Fort Street High School, Sydney, 1872. (Source: 
http://acms.sl.nsw.gov.au/item/itemDetailPaged.aspx?
itemID=479562. Accessed 17 November 2019)
On his return to Fiji in about 1879, at the age of 15, 
he entered the business of Messrs W. Kopsen and Co., 
a fi rm that had been established in Levuka in 1875 to 
import and trade in textiles and general merchandise, 
as an assistant. He stayed there for several months. 
Around 1880 he entered the Government service as as-
Figure 15. Th e Hospital, Levuka, Fiji, 1884. (Source: 
https://collections.tepapa.govt.nz/object/20766. Accessed 17 
November 2019)
After completing this period of practical training it 
seems likely that he followed his older brothers, Arthur 
and William, in travelling to London,95 attending one 
of the crammer schools of pharmacy there, and taking 
the Minor examination of the Pharmaceutical Society 
of Great Britain, for we learn that he passed ‘his exam-
ination as a pharmaceutical chemist’ about 1885.96 He 
immediately returned to Fiji, and spent the rest of his 
life in Levuka.
William started manufacturing aerated water for his 
father. However, this was clearly not a full-time commit-
ment, since we learn that ‘Mr Swann entered the service 
of Messrs Hedemann and Co., merchants of Levuka, in 
the year 1892, as an assistant, and has retained that po-
sition ever since, and has also carried on the fi rm’s chem-
ist’s department for the last six years [since 1901].’ He 
continued in that position at least until 1907, in which 
year his occupation was described as that of ‘a pharma-
ceutical chemist and aerated water manufacturer’.97
It is clear, however, that throughout this period he 
was closely involved with his father’s business, which 
had been founded in 1870. But in 1894 his father had 
a paralytic fi t and was no longer able to run it, taking 
retirement at the age of 60. Frederick took over control, 
and continued to run it until his own death. Th e fam-
ily were clearly well-connected in Fiji, and in 1886, at 
the age of 22, William married Mary Agnes, the third 
daughter of the late Sir Charles St Julian, who had been 
the fi rst Chief Justice in Fiji from 1872 until his death 
in 1874. Between 1887 and 1907 the couple had eight 
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children: one son died, but three sons and four daugh-
ters survived into adulthood. 
William Swann died in Levuka in Fiji on 28 Sep-
tember 1924, shortly before his sixtieth birthday.
Conclusion
When James Butler Swann set off  with his family from 
a small village in Lincolnshire for a new life in New 
Zealand in 1862, he could scarcely have imagined 
where his family might end up. Th is article has sought 
to explain what led an ordinary English family to up-
root themselves, and to start a new life on the other side 
of the world. It has illustrated how the move was facil-
itated by networks established through the Anglican 
church, and how the initial prospect of joining a new 
and expanding Anglican community off ered a promis-
ing business opportunity for a young pharmacist. Eco-
nomic circumstances back home may also have also 
have played a part.
Th e family’s second migration to Fiji in 1867 was 
undoubtedly motivated by the prospect of greater fi -
nancial rewards from cotton cultivation, coupled with 
concerns over both fi nancial viability and personal safe-
ty in New Zealand. Although this venture ultimately 
failed, Swann was able to fall back on his qualifi cation 
as a pharmaceutical chemist. Th e trade was obviously 
suffi  ciently robust to persuade three of his sons to fol-
low in his footsteps. His fi rst son set up in business on 
a neighbouring island; the second established a new 
business in Samoa; and the third eventually took over 
his father’s original business on Fiji. 
Th is family’s story vividly illustrates the exhilarat-
ing mix of opportunities, threats and international po-
litical events that characterised the second half of the 
nineteenth century at a time of colonial expansion, in-
creasing commerce and mass cultivation. A complex 
and dynamic pattern of social, political and economic 
factors help to explain the decisions people made and 
their enthusiasm for overseas ventures with all their 
risks. Swann’s story highlights the signifi cance of net-
works, of links forged through the church, through so-
cial connections and through occupation. 
Th ere were clearly great fi nancial opportunities cre-
ated both by growing migrant populations (as in New 
Zealand) and the exploitation of land for profi table crops 
(such as cotton in Fiji). But long journeys by sea carried 
their own risks, and the Swann family did well to avoid 
them. More signifi cantly, however, treaties between Brit-
ish governments and local chiefs were often fragile, as in 
both New Zealand and Fiji, and new immigrants bore 
the brunt of the resulting consequences.
Th e challenges faced by the family were those en-
countered by all immigrant communities; they includ-
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A R T I C L E
Desperate housewives: Th e rise and fall of 




In the early twentieth century British temperance re-
formers tried to restrict the sale of medicated wines, a 
popular form of patent medicine. Medicated wines usu-
ally contained between 15 and 20 per cent alcohol. 
With vague labels, department store retailing and fl or-
id advertising, they were very popular. Th e United 
Kingdom Alliance – the leading temperance organiza-
tion at the time – attacked medicated wines in print, 
before the Select Committee on Patent Medicine in 
1914, and in a court case in 1913. Th ey were not suc-
cessful, because their own testimony revealed divided 
professional opinions about the effi  cacy of medicated 
wines.
Introduction
Th e spectre of female teetotallers soaked in liquor, dirty 
and lying in the gutter, made compelling propaganda 
for temperance in early twentieth-century Britain. Re-
formers argued that many unsuspecting women were 
being led down a slippery slope to alcoholism by med-
icated wines. Medicated wines or tonics were a form of 
patent medicine (or over-the-counter drug).1 Taken dai-
ly as an apparently harmless pick-me-up, they were sold 
under trade names that were famous to Victorians – 
Wincarnis, Hall’s Wine, Guy’s Tonic, Vin Mariani and 
Sanatogen. 
Few were actually patented.2 Th eir composition var-
ied; some had beef extract, some had cocaine. But all 
contained large quantities of alcohol, generally between 
15 and 20 per cent alcohol, as opposed to the average 
table wine which contained only 9 per cent alcohol.3 
Consumers were encouraged to think otherwise. First, 
makers were not required by law to declare the alco-
holic content of medicated wines on product labels. 
Second, fl orid advertisements for medicated wines por-
trayed them as innocuous remedies for general conva-
lescence, fatigue and ailments associated with mater-
nity. Th ird, depending on the district, many medicated 
wines were sold in unlicensed department stores and 
grocery stores. 
To members of the leading temperance organiza-
tion, the United Kingdom Alliance (UK Alliance), 
these three factors constituted a misrepresentation of 
the product which was luring innocent women to ine-
briety and destroying their lives. In the early 1900s the 
UK Alliance launched a campaign to restrict the sale 
of medicated wines. It failed by 1914, I will argue, be-
cause temperance reformers relied on medical evidence 
to bolster their case: in fact it undermined it. 
Opportunistically, but fatally, temperance tethered 
its social construction of the medicated wine menace to 
the professional medical lobby. On the face of it, this 
approach seemed logical. In the l890s the British Med-
ical Journal, under the editorship of Ernest Hart, had 
launched an assault on the general category of patent 
medicines. In a series written on behalf of the British 
Medical Association, and later published in 1909 and 
1912 as Secret Remedies and More Secret Remedies, doc-
tors argued that patent medicines were addictive or po-
tentially lethal, that they masked symptoms, that they 
delayed vital professional treatment, and that they of-
fered false cures.4 
Contemporaneously, the Pharmaceutical Society of 
Great Britain had lobbied to secure the 1908 Pharmacy 
Act. Th e Pharmacy Act stipulated that a patent medi-
cine which contained more than one per cent of co-
caine, morphine or opium could only be sold by phar-
macists.5 Temperance reformers thought that they 
could capitalize on both recent professional eff orts. 
Th ey hoped to focus an already whetted public interest 
on the secret presence of alcohol in medicated wine.6 
To achieve victory they needed to be wholly convinc-
ing. I will show that they failed dismally in print prop-
aganda, before a Select Committee of the House of 
Commons, and in court. In the end they held passion-
ate opinions, but they simply did not (or would not) 
appreciate the divisive nature of professional opinions 
about alcohol at the turn of the twentieth century.
Th e temperance critique of medicated wine
In terms of chemical composition, medicated wines 
looked like an easy target for restrictive legislation. 
Medicated wines were largely products founded in the 
late nineteenth century, though some purported to have 
a longer history.7 Th ough hard to defi ne, in popular 
parlance a medicated wine or tonic was generally a wine 
that was one blended with other ingredients. But med-
ical, pharmaceutical and legal understanding of the 
term varied. Doctors such as Robert Hutchison, physi-
cian to the London Hospital, posited that ‘medicated 
wines are concoctions, the basis of which is port or 
sherry, to which has been added extract of beef, extract 
of malt, peptone, pepsin, cocoa leaves, cocaine, cincho-
na, iron or some other dietetic or medicinal substance’.8 
Chemists were quite precise about the proportion 
of wine to medicine: the British Pharmacopeia stated 
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that if a wine contained a grain or more of quinine per 
fl uid ounce it was then a medicine.9 Th e government, 
for the purpose of excise, tax, and licensing, favoured a 
more amorphous assessment. Th e government required 
only that ‘the characteristic feature of “medicated wine” 
[is] that it shall not be capable of being used as a bever-
age.’10 Accordingly, packaging and advertising empha-
sized medicinal eff ects (Figure 1).
be sold virtually anywhere. Indeed, most medicated 
wines were sold in department stores or unlicensed gro-
cery stores.13 Th e department store boom – that had 
begun around 1889 with the founding of William 
Whiteley’s store in London – allowed women in par-
ticular to buy a medicated wine during a generally re-
fi ned and female-oriented shopping trip. Alcoholic 
drinks could only be sold in a licensed establishment, 
an arena few respectable women would dare to frequent 
without a male escort.
Medicated wines fell within a grey area of the law. 
A medicated wine could be sold in an unlicensed shop 
provided that it was to be used as a medicine, not as a 
beverage. Th e judgement about whether a wine was so 
medicated as to be incapable of use as a beverage was 
left to the police. One district might require a license 
for the sale of medicated wine; another might not. Th e 
result was that many products with high alcohol con-
tent were made broadly (but unevenly) accessible to 
consumers at many grocery stores and department 
stores. Th e availability of medicated wine in shops fre-
quented by women was a concern to temperance advo-
cates.
Medicated wine, however, was given its greatest 
boost by its wide availability in most chemists’ shops, 
where it appeared to have a professional seal of approv-
al. Despite the united movement in the early 1900s 
within the pharmaceutical profession to restrict the sale 
of morphine and opium, the sale of alcohol elicited 
more varied opinions. Th at should have been a sign to 
temperance enthusiasts that restricting medicated wine 
might be diffi  cult. Th e Pharmaceutical Journal, the or-
gan of the Pharmaceutical Society of Great Britain, did 
not condone the sale of medicated wines by chemists. 
It took the position ‘that we have always endeavoured 
to discourage the taking out of licenses to sell wine as 
being inconsistent with the pharmacist’s proper busi-
ness’. Since many of the ‘so-called medicated wines…
admit to being used as beverages, no real distinction 
can be drawn between them and other alcoholic bever-
ages, and thus their sale lies outside the scope of strict 
pharmaceutical practice’.14 
In districts where the licensing laws were interpret-
ed strictly, some chemists even took out wine licenses 
in order to be able to off er their customers the medi-
cated wines they demanded. For chemists, navigating 
the transition from ‘bespoke’ products to ‘off -the-peg’ 
(as Stuart Anderson has put it), business considerations 
made it risky to refute the claims of prominent makers, 
and especially to refuse to stock them.15 As one chemist 
put it ‘prudence [urges] that it would be bad policy to 
teach customers to go to some other class of shop when 
they want medicine of any kind’.16 Th e Chemist and 
Figure 1. Advertisement for Hall’s Wine (Source: Illus-
trated London News, 21 January 1899: 101)
Science Siftings, the popular scientifi c magazine and 
forerunner of Science, analyzed brands such as Guy’s 
Tonic, Wincarnis, Vibrona and Vin Mariani. It conclud-
ed that ‘fi guratively speaking…[a medicated wine or 
tonic] may mean anything’,11 but most medicated wines 
contained more alcohol than the average table wine. 
Vin Mariani contained 14 per cent alcohol; Guy’s Tonic, 
Hall’s Wine and Buckfast Tonic Wine each contained 15 
per cent alcohol; and Wincarnis contained 19.5 per cent 
alcohol. In contrast, the average table wine contained 
only 9 per cent alcohol.12 Alcoholic content was almost 
never listed on the product label, nor was it required by 
law. Th e high percentage of alcohol in medicated wines 
attracted a lot of temperance attention.
Point of sale was another problem for temperance 
advocates. Unlike table wine, medicated wines could 
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Druggist reported that the number of chemists applying 
for a wine license was increasing in the 1890s. In 1892 
28 new wine licenses were granted, 27 were granted in 
1893 and 45 were granted in 1894. It concluded that 
‘chemists are preparing in growing numbers to meet the 
demand which undoubtedly exists for medicated 
wines’.17 
At the chemists’ shops, wines were removed from 
the potential stigma of a licensed shop and seemed cred-
ible as bona fi de medicines. In the words of one judge 
who assessed a licensing dispute, the sale of medicated 
wines by patent medicine dealers was a way ‘to com-
mand a large sale of rather inferior port at a compara-
tively high price with the aid of persons who do not 
ordinarily sell wine to persons who do not ordinarily 
buy it’.18 Th is latter point seemed more compelling to 
reformers than diff ering points of view within the phar-
maceutical profession. It will become clear that temper-
ance reformers should have heeded confl icting opinions 
among chemists as ominous for their eff orts to restrict 
the sale of medicated wines. 
It seemed plain enough that medicated wines were 
being pitched as products for middle-class women, an 
aspect that held potential as a rallying cry for protective 
legislation. Th e price point was high. Medicated wines 
were generally sold in three sizes, ranging from 1s 1d to 
11s 1d per bottle (compared to, say, Beecham’s Pills that 
started at 9d and rose only to 2s 9d for the largest size). 
In addition to the relatively high price, the advertising 
– especially prominent in women’s magazines and in 
the religious press – targeted women, both explicitly 
and implicitly. Makers claimed that medicated wines 
were universal panaceas for sleeplessness, weakness, ex-
haustion, infl uenza and nervous disorders. But adver-
tisements repeatedly emphasize female complaints – 
anaemia (most common in menstruating women), 
recovery from childbirth, menstrual pain and ‘mater-
nity weakness’.19 
Florid advertising imagery emphasized the female 
orientation of the market through the visual trope of 
the female invalid and the angel. Women were born 
again through use of medicated wine. An advertisement 
for Sanatogen pictures a female patient who stands, sup-
ported by her nurse, arms outstretched before an open 
window. Imitating the converted, who has risen to gaze 
towards heaven, the woman looks into the sky and sees 
her saviour, Sanatogen, spelled out in a rainbow (Fig-
ure 2).20 
Other advertisements picture angels with gigantic 
wings,21 or dramatize before and after conditions. For 
Figure 2. Advertisement for Sanatogen (Source: Illustrated London News. 19 August 1911: 317)
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example, a woman sits slumped in her chair, her cheek 
resting on one hand. Her nurse stands by with the doc-
tor, off ering a glass of Wincarnis. In the ‘after’ picture, 
she is a smiling hostess serving tea to the doctor and her 
beaming husband.22 Th e popular commercial gambits 
of the fl uttering angel and the risen invalid focused on 
women, especially women of child-bearing age.
Th e other major marketing strategy of medicated 
wine-makers was to proclaim endorsement by chemists 
and doctors. Quotes from chemists tended to empha-
size sales rather than effi  cacy. For example, one chemist 
reported ‘the sale is certainly satisfactory; another that 
he sold ‘almost nothing but Guy’s’; yet another that 
there was a ‘tremendous turnover’.23 Careful scrutiny 
shows that the chemists were focusing on retaining cus-
tomers, but a cursory glance at the list of quotes and 
chemists’ names might easily suggest product endorse-
ment. Testimonials from doctors, which were extreme-
ly common in medicated wine advertisements, were 
more clearly endorsements of the effi  cacy of the prod-
uct. For example, in an advertisement for Wincarnis an 
image dramatized a transformation from prostration to 
convalescence. Text below the image proclaimed ‘Over 
6,000 Testimonials received from Medical Men’ (Fig-
ure 3).24 
and the galling use of religious imagery in the Christian 
press, were all calls to action for temperance advocates. 
Temperance critics thought they were on solid ground, 
not just because of the merit of their arguments, but 
because patent medicines as a general category had been 
so routinely vilifi ed not just in the British Medical Jour-
nal, but in British literary circles. 
George Eliot, in Felix Holt (1866), had described 
them as ‘absurd’ and likened their ‘gulling advertise-
ments’ to pickpocketing.26 Joseph Conrad, in Th e Secret 
Agent (1907), had characterized their inventors as ‘mor-
al nihilis[ts]’ who ‘live on the vices, the follies or the 
baser fears of mankind’.27 Perhaps most famously, H.G. 
Wells in Tono Bungay (1908) had portrayed the suppos-
edly quintessential patent medicine maker, Edward 
Ponderevo, as a confi dence trickster who markets an 
out-of-date remedy which is ‘slightly injurious rubbish’ 
through ‘alluring’ advertisements.28 
Vanity Fair, Th e Times, and the Saturday Review 
suggested colourfully that the patent medicine business 
was the ‘safest of all fi elds for cynical knavery’ which 
off ered ‘large incomes to the greatest numbers of vulgar 
imposters’,29 the most ‘parasitic in modern 
civilization’30who ‘plunder[ed]’ and ‘injur[ed]’ the 
‘trustful’.31 Within this climate, in the fi rst decades of 
the twentieth century, British temperance reformers 
projected their opposition to the menace of medicated 
wines in three venues: to its own constituency in its of-
fi cial organ, the Alliance News; to a broader public 
through the expert testimony of Dr Mary Sturge before 
the House of Commons’ Select Committee on Patent 
Medicine in 1911; and fi nally in court, in the case of 
Bendle versus the Alliance News in 1913. As we shall 
see, their construction of the medicated wine menace 
was fatally fl awed.
Attacking medicated wines in print
Temperance advocates publicized the dangers of medi-
cated wines within the pages of the Alliance News. Th e 
Alliance News was the weekly newspaper of the UK Al-
liance, with an estimated circulation of about 20,000 
by the 1890s, of which about 5,000 copies were distrib-
uted to the unconverted. Generally, its focus was in-
sider news about the temperance campaign, local meet-
ings, leaders and activities, and temperance products. 
Attempts to generate a wider circulation that would 
make it competitive with national weeklies had largely 
stalled due to the narrowness of its content. But it re-
mained an important in-house organ for temperance 
reformers to communicate about issues to each other.32 
With regard to medicated wines, the focus of cri-
tiques in the Alliance News was inadequate labelling 
and danger to women. Doctors – as authors and cited 
Figure 3. Advertisement for Wincarnis (Source: Illustrat-
ed London News. 1 June 1901: 802)
Th e supposed endorsement by medical professionals, 
highly memorable female imagery and wide availabil-
ity formed a winning combination. By 1910 medicated 
wines were big business. Th e proprietors of Wincarnis 
and Hall’s Wine wielded a capital of £250,000 and 
£175,000 respectively.25 
Th e scale of the business, the use of alcohol in the 
product, the publication of what temperance advocates 
assumed to be phoney endorsements from chemists and 
doctors, the targeting of unsuspecting women (the 
backbone of the teetotal and temperance movements) 
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experts in articles – described a series of problems. No 
consumer could rely on the labels on the bottles for con-
tent or safe dosing. Many takers, being sick already, 
were especially vulnerable. Even worse, some of the vic-
tims of medicated wines ironically were unaware teeto-
tallers. But once they took medicated wines they devel-
oped a habit. Th e danger of medicated wines was that 
‘…those who indulged in them would probably not take 
the ordinary wine, knowing its danger, but thought 
that in the medicated wines the danger had been re-
moved and the eff ect of the alcohol possibly neutral-
ised’.33 Women were particularly likely to be duped. 
Writers for the Alliance News editorialized that the as-
sociated rise of drunkenness among women had grave 
social consequences: ‘it was bad enough when the father 
drank, but when the mother drank life was poisoned at 
its foundation’.34 
In addition to the articles in the Alliance News, the 
UK Alliance produced pamphlets aimed at the non-
temperance community. Between 40,000 and 60,000 
pamphlets were distributed for ‘magistrates, invalids 
and the general public’.35 Pamphlets used strong lan-
guage, typically characterizing medicated wines as ‘di-
abolically deceptive and insidiously injurious’.36 Th ey 
always drew on the opinions of eminent medical au-
thorities from the British Medical Journal, and ended 
with signatures of doctors who endorsed the pamphlet. 
Th e emphasis in the articles of the Alliance News and in 
its pamphlets for a general audience was on the medi-
cal critique; doctors, they claimed, concurred with tem-
perance advocates that medicated wines were danger-
ous.
Attacking medicated wines before a Select Commit-
tee
Th e parameters of the medicated wine menace sketched 
out in the Alliance News and in pamphlets were elabo-
rated by Dr Mary Sturge (1865-1925) in testimony be-
fore the Select Committee on Patent Medicines in 1911. 
Sturge – a Quaker and niece of the Birmingham may-
or Charles Sturge – held a medical degree from the Uni-
versity of London. She was only the second woman to 
practice medicine in Birmingham and was a physician 
at the Birmingham and Midland Hospital for Women. 
Part of an activist family, whose public service dated 
from the abolitionist activities of Joseph Sturge, she was 
a member of the Birmingham Society for Women’s Suf-
frage and a lifelong supporter of temperance.37 She had 
also recently co-authored with Sir Victor Horsley (1857-
1916) – the prominent neurosurgeon from University 
College, London – Alcohol and the Human Body (Mac-
Millan, 1907), which had garnered considerable atten-
tion in the press for its controversial assertions of the 
eff ect of parental alcoholism on children.38 
Sturge was certainly a prominent name. Moreover, 
to have a female physician speaking to a problem that 
purportedly victimized women made rhetorical sense. 
For two days Sturge outlined problems related to dos-
ing, labelling, retailing and advertising. Th e usual rec-
ommended dosage of six ounces a day, she said, was too 
much. Th is was enough alcohol for a chronic user to 
develop a dependence on alcohol, especially if the user 
was a woman. After confi nement, Sturge said, women 
existed in a ‘weakened’ state that might make them ‘un-
able to resist temptation’.39 Women had less powers of 
resistance than men because ‘Woman’s nervous sys-
tem…is always working at a stress from childbearing…
Altogether women have more of a fi ght to get through 
life than men physically, and therefore it is more dan-
gerous for them to be drugged’.40 Th e vulnerability of 
women to the recommended dosages was the fi rst plank 
in Sturge’s attack on medicated wines.
Another was the fear that poor labelling might 
make teetotallers the unwitting victims of a ‘morbid al-
coholic habit’. White Ribboners – young girls who had 
taken the pledge – might take these drinks ‘without the 
least idea that by thus doing they are breaking their 
pledge’.41 She off ered narratives of teetotallers corrupted 
by medicated wines. Almost always the narratives in-
volved a promising young woman convinced by others 
to take a medicated wine. Th e innocent woman became 
addicted and ultimately lost all control. Th e stories did 
not deny volition, but they shifted the focus of culpa-
bility onto the medicated wine makers who did not in-
form the consumer of alcoholic content. 
Free choice had been taken away from women by 
deceptive labelling. Here, Sturge had to combat some 
skepticism. As Th ora Hands has sensibly argued, it was 
reasonable to assume that most consumers of medicat-
ed wines expected a ‘wine’ to contain some wine.42 But 
Sturge countered that argument with the contention 
that teetotalers were more ‘gullible’ than other people 
because ‘they know less about the whole thing’.43 Ac-
curate labelling was necessary to protect the innocent.
Finally, the point of purchase – often at unlicensed 
grocers and chemists – was a problem. Sturge contend-
ed ‘I fi nd the most harm is done by the druggists press-
ing their sale on ignorant women’.44 She cited a young 
pregnant woman, her own patient, whose symptoms 
seemed curious until Sturge noticed a large bottle of 
Wincarnis in the bedroom. She discovered that the 
woman was drinking two bottles a week. She began 
taking it on the ‘strong recommendation of the drug-
gist next door’.45 Sturge reported that there were two 
grocer’s shops near her hospital; one with a window full 
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of wines and one without. Th e grocer who did not sell 
them conceded that while he upheld moral principles, 
he would ‘make [a] fortune’ if he relented.46 In each 
case, profi t motivations prevented the vendor – even the 
professional one – from disclosing the alcoholic con-
tent. Unlicensed establishments, Sturge argued, should 
not sell alcohol because their advice was not reliable.
Beyond the labelling and licensing arguments, 
Sturge devoted a good part of her testimony to terrify-
ing tales drawn from doctors themselves. Th e medical 
testimony was crucial to her case. One doctor wrote of 
a female patient, 22 years of age, of substantial means, 
refi nement and education, who was found ‘unkept and 
unwashed…the stale smell of alcohol pervading the at-
mosphere…laughing, crying and shrieking in turns…
[She was later discovered] lying drunk in a lane a few 
yards from her home’. Another doctor described a shop-
keeper’s wife reduced to homelessness. A third wrote of 
a woman recovering from childbirth who ended up 
‘hopelessly insane’.47 A common theme was an ending 
that would be especially horrifi c to a respectable wom-
an; dirtiness, homelessness or insanity. 
Terrifying tales told by scores of doctors were part 
of the temperance strategy against medicated wines. 
Th is made the advertising tactics of the medicated wine 
makers especially egregious. Advertisements for medi-
cated wines almost always included testimonials from 
doctors. According to Sturge, these testimonials were 
solicited and presented duplicitously. At the bottom or 
side of most advertisements for medicated wine was a 
coupon (Figure 4). 
advertisements. Sturge alleged that thousands of signa-
tures were obtained from doctors using this method.48 
Th e advertising of doctors’ recommendations was a cha-
rade, the ultimate form of false advertising. Speaking 
on behalf of the UK Alliance, Dr Mary Sturge gave 
dramatic testimony. 
 As a woman doctor from a prominent family, she 
seemed at fi rst glance to be a credible witness. She 
spoke as if she represented the entire medical profes-
sion in her blanket opposition to medicated wines for 
inadequate labelling, inadequate licensing and false 
advertising. But this was far from the case. While 
some doctors – and certainly most who supported the 
temperance lobby – agreed with her opposition to al-
cohol, it was well known that there were doctors who 
defended the medicinal use of alcohol for analgesia 
and even nutrition. 
If Sturge and Horsley had simply been on the tem-
perance side of a legitimate medical debate, they might 
have still seemed credible. But much of their case had 
been discredited just the year before. Th e very data on 
which they based their opinions had been very publi-
cally questioned. Temperance advocates must have 
known that in 1910 prominent scientists, including the 
noted mathematician Karl Pearson, had rebutted Hors-
ley’s statistics about the eff ect of parental alcoholism on 
children. 
Th e controversy had spilled over from the pages of 
the British Medical Journal and Th e Lancet into Th e 
Times. In an editorial on 13 January 1911, the editors 
of Th e Times advised the public to ‘disregard the din of 
the controversy’ – in eff ect to ignore Sturge and Hors-
ley on the evils of alcohol. Letters appeared on the sub-
ject every day for two weeks.49 Th e temperance lobby 
had chosen an expert whose fi ndings had been serious-
ly questioned the previous year. Th e credibility of their 
main medical witness was shaky. Even if large parts of 
her testimony had nothing to do with parental alcohol-
ism, readers of the report of the Select Committee 
might well wonder if her testimony was reliable or 
trustworthy in the light of what they had read recently 
in Th e Times.
Temperance lobbyists may have thought that the 
public would not be able to follow the intricacies of the 
statistical debate. But they must have known that a cru-
cial part of her testimony rested on an assumption for 
which she had no proof. Sturge assumed that no doctor 
would really endorse any patent medicine, let alone a 
medicated wine. Here, she assumed that doctors would 
follow medical ethics, which had stipulated since Per-
cival’s Medical Ethics was published in 1803 that no 
doctor should recommend a medicine if the contents 
were unknown. 
Figure 4. Advertisement for Wincarnis (Source: Illustrat-
ed London News. 4 March 1905: 325)
If the doctor signed it and sent it to the company offi  ce 
the patient could receive a free sample. Any doctor who 
refused a patient’s request to sign a coupon was put in 
an awkward position. But if he did sign it, his signature 
was then reproduced in a phoney endorsement in later 
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Following Sturge’s testimony, proprietors of major 
medicated wine manufacturers were called to testify. 
Shockingly, manufacturers were able to produce thou-
sands of legitimate medical endorsements. Not only did 
they have bona fi de testimonials, but Hall’s Wine had 
twenty-one doctors who were large shareholders, and 
two doctors on their board of directors.50 Hall’s Wine 
was not alone. Th e makers of Wincarnis similarly had 
over 10,000 letters from doctors.51 Following the release 
of the Select Committee Report, Hall’s Wine took out 
a full-page advertisement that emphasized ‘Th e Voice 
of Medical Opinion’ above a picture of a mature man, 
presumably a doctor (Figure 5). Th e text reads: 
Th ousands of doctors have written asking for sup-
plies for urgent cases – others say they have tried 
Hall’s Wine, or used it in their own homes, to the 
benefi t of themselves and their families. Hundreds 
of others send a word of thanks for the results 
achieved. Th ese letters from doctors are eloquent tes-
timony to the benefi t derived from Hall’s Wine.52 
Th e Select Committee, which might have given the UK 
Alliance its shining moment, in fact wound up reveal-
ing that many doctors did indeed endorse them, just as 
the advertisements claimed.
Attacking medicated wines in court
Th e temperance lobby found itself unprepared not only 
before the Select Committee, but also in court. In 1913 
the UK Alliance was taken to court for libel by a mak-
er of a medicated wine. Th e Alliance had published a 
pamphlet, authored by a solicitor, Robert Batty, de-
nouncing medicated wines. Among the products 
named was Bendle’s Malt-Port Nutrient. Th e Batty pam-
phlet was typical in its hyperbolic denouncements. It 
called the products ‘wines of death’ and said that mak-
ers were ‘veritable masters of mendacity’. It included 
signatures of doctors, and took particular aim at the 
maker’s claim that such wines were nutritious, even 
strengthening. Batty suggested in the pamphlet that 
‘these wines contain such a ridiculously small quantity 
of beef extract that they cannot be really strengthening, 
and that the claim by their makers for their use on this 
ground is positively absurd’.53 In fact, Batty claimed, all 
it contained was 20 per cent alcohol, as proven by a 
chemical analysis published in the British Medical Jour-
nal.
In court, the makers of Bendle’s Malt-Port Nutrient 
argued that they had been damaged by the pamphlet. 
Th ey showed that the analysis published in the British 
Medical Journal was incorrect. (Indeed, the British 
Medical Journal published a correction two issues later 
after complaints by the manufacturer, but Batty had 
failed to take the correction into account). Expert tes-
timony by Mr Pary, Fellow of the Chemical Society, 
and Dr Willcox, Senior Analyst to the Home Offi  ce and 
Physician at St. Mary’s Hospital, London, suggested 
that the wine did indeed have nutritive content. 
On this basis the UK Alliance was found guilty of 
libel, and banned from naming Bendle’s Malt-Port Nu-
trient in any future publication.54 Clearly, this was an 
embarrassing outcome for the temperance lobby. Th e 
court case, like the testimony before the Select Com-
mittee, rested on infl amed rhetoric rather than sound 
medical support. Th e use of the medical profession by 
the temperance lobby did not work. 
Th e temperance lobby underestimated the divisive 
stature of alcohol and patent medicine within the med-
ical profession. Alcohol itself was still controversial. Th e 
British Medical Temperance Society had been formed 
in 1876; by 1898 it had over 900 members. Certainly, 
this group challenged the effi  cacy of alcohol in medical 
treatment. But the profession as a whole was fraught 
with internal divisions about the eff ect of alcohol on the 
human body, about whether the craving for alcohol 
might be inherited, and about the relationship between 
Figure 5. Advertisement for Hall’s Wine (Source: Illus-
trated London News. 8 March 1919: 347)
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inebriety and insanity. For example, members of the 
Society for the Study of Inebriety, founded in 1884, fa-
voured the disease model of alcoholism, and opposed 
temperance colleagues as ‘unscientifi c’ and zealous.
Similarly, moderationists opposed them; they fa-
voured drinking in moderation.55 Th ere was no uni-
formity. In practice, many doctors continued to recom-
mend alcohol as a treatment for common complaints. 
Th e Bendle’s Malt-Port Nutrient court case in 1913 
showed that the nutritive properties of alcohol, a long-
standing debate in the medical literature, might still be 
an open question. As late as 1891 the treatment of in-
fl uenza with alcohol was so popular that it was satirized 
in Punch.56 Clearly there were internal divisions within 
the medical profession over the use of alcohol, which 
did poke holes in the temperance contention that doc-
tors opposed the use of medicated wine.
Second, the revelation that doctors had written 
bona fi de endorsements for medical wines and were 
even shareholders exposed the harsh reality that the re-
lationship between orthodox medicine and commercial 
medicine was often murky. Th eoretically, doctors were 
not supposed to recommend medicated wines, because 
– like all patent medicines – their composition, and 
therefore, potentially detrimental eff ects, were un-
known. Th is had been laid out in Th omas Percival’s 
Medical Ethics in 1803;57 and endorsed in an 1888 reso-
lution of the Royal College of Physicians.58 
But, as Peter Bartrip has shown at the organiza-
tional level, the reality was often very diff erent.59 Doc-
tors, at the grass-roots level, similarly were not im-
mune to mass marketing, including advertising. Some 
doctors may have been seduced by free samples; some 
may have genuinely found a particular product thera-
peutically useful; and some may have been pressured 
by patients. Temperance doctors, such as Sturge, 
clearly hoped that even doctors who supported the 
therapeutic use of alcohol would not support the use 
of patent medicine. Th ey were wrong. It appeared that 
the temperance lobby had misrepresented a signifi cant 
part of their case. 
Finally, in the absence of wholehearted medical 
condemnation, many observers must have wondered if 
a little self-medication with alcohol disguised as medi-
cine was really so bad. If doctors were prepared to use 
alcohol therapeutically, many customers were prepared 
to drink it for health. Medicated wines provided a way 
for customers who would not buy regular wine or spir-
its to consume alcohol under the cloak of taking med-
icine. For those who sought relief from minor aches and 
pains or who needed a pick-me-up, medicated wines 
were convenient and readily accessible, without the 
trouble of contacting the doctor. Th ey also gave the pa-
tient some control; she picked the remedy for her own 
complaint. 
As John Crellin has demonstrated, by the turn of 
the century there was an increasingly pluralistic medi-
cal market for self-care.60 Th e convenience, access and 
lack of stigma attached to medicated wine made it a 
popular product, one that was diffi  cult for legislators to 
take restrictive action against without much more con-
vincing arguments than the ones temperance advocates 
were able to provide by 1914.
Conclusion
In the end the temperance attack on medicated wines 
failed. While rhetoric against medicated wine purport-
ed to be scientifi c, much of it relied on terrifying tales 
of women sodden with liquor. Th e tales were memora-
ble but anecdotal. Temperance advocates tried in the 
pages of the Alliance News, before the Select Commit-
tee and in court, to bolster their anecdotal evidence 
with medical opinions. But unfortunately, they pre-
sented medical opinions about which there was little 
consensus. Th e case against medicated wines ignored 
altogether the divisions within the profession about 
temperance; it was by no means clear on the eve of the 
First World War that alcohol had no therapeutic effi  -
cacy. 
Nor it could it be proven that medicated wine had 
no nutritional merit; this too was open to scientifi c de-
bate. Even basic facts about chemical composition were 
quoted incorrectly in anti-medicated wine literature. 
Th e scientifi c evidence wound up being inconclusive. 
Th e revelation that doctors themselves endorsed patent 
medicines and sat on boards of directors of medicated 
wine companies underscored the divisions in the pro-
fession. Temperance advocates were left with sensation-
al tales of women in the gutter. It was simply not 
enough.
Medicated wines continued to be marketed to mid-
dle-class women throughout the twentieth century. Af-
ter the Pharmacy and Medicine Act of 1941 required 
labelling of active ingredients, including alcohol,61 
many medicated wines reinvented themselves, at least 
in advertisements, by focusing on vitamin content. Th e 
alcohol remained and the products continued to be sold 
without a license.
Th roughout the 1960s and 1970s the alcohol con-
tent was only thinly disguised in advertisements which 
emphasized the utility of the product as an escape for 
women who thought ‘kids are murder!’62 Today, Sana-
togen is still on the market as a ‘tonic wine with added 
iron’.63 Vin Mariani relaunched in 2014 as ‘an excep-
tional Bordeaux wine fortifi ed with Peruvian cocoa 
leaf ’ 64 and 22 per cent alcohol; and Wincarnis is sold 
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currently by Ian MacLeod Distillers as a ‘Tonic and 
Ginger Wine’ fortifi ed with ‘energy-giving Vitamin B 
Complex’ and 14 per cent alcohol, enjoyable ‘on its own 
or as a Gin and Win’.65 
Today, most medicated wines are made and sold by 
wine merchants and distillers. In contrast to the female 
orientation of the market for Edwardian medicated 
wines, some of the most popular medicated wines now 
have a distinctly masculine consumer base. For exam-
ple, Buckfast Tonic Wine, a caff einated wine with 15 per 
cent alcohol from Devon – fi rst marketed by Buckfast 
Abbey in 1880 and today sold by J. Chandler & Co. – 
is among the best-selling alcoholic beverages in Britain; 
it has a notorious linkage with violent male crime. In 
2015 the Scottish prison service reported that over 43 
per cent of inmates drank Buckfast Tonic Wine before 
their previous off ence.66 
Th e medicinal use of alcohol has become notorious 
once again. One hundred years after the 1914 Select 
Committee report, despite the fervent eff orts of the UK 
Alliance in print and in court, medicated wines thrive. 
Th ough their opponents’ fame has faded with time, the 
brand names Wincarnis, Sanatogen and Buckfast Tonic 
Wine, for good or for ill, are still recognizable as an in-
tegral part of modern British consumer culture. 
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Th e development of pharmacy education 
in the Republic of Tatarstan, Russia, 
1804-1975
Ruzaliya Tukhbatullina and Alsu Kuznetsova
Abstract
Th is article describes the origins and development of 
pharmaceutical education in the Republic of Tatarstan, 
Russia. Th e Imperial Kazan University was established 
in south central Russia in 1804. One of its four facul-
ties was a Division of Medical Sciences, which included 
a Department of Chemistry, Technology and Pharma-
cy. Th e need for a separate School of Pharmacy at the 
Kazan State Medical University was recognized in 
1919, but no action was taken. In 1930 the Medical 
Faculty became the Kazan Medical Institute, and in 
1975 a Faculty of Pharmacy was opened within it. In 
2018 this became the Institute of Pharmacy within the 
Kazan State Medical University. 
Аннотация
В статье рассказывается об истоках развития 
фармацевтического образования в Республике 
Татарстан (Россия). Первый российский универ-
ситет был основан в Москве в 1755 году, а Импе-
раторский Казанский университет – в 1804 году. 
Одним из четырех его факультетов было отделе-
ние медицинских наук, в состав которого входи-
ли факультет химии, технологии и фармации. 
Потребность в фармацевтической школе при Ка-
занском государственном университете была 
признана в 1919 году, но никаких действий пред-
принято не было. В 1930 году медицинский 
факультет стал Казанским медицинским инсти-
тутом, а в 1975 году в нем был открыт фармацев-
тический факультет. В 2018 году фармацевтиче-
ский факультет был реорганизован в Институт 
фармации при Казанском государственном меди-
цинском университете. 
Th e origins of higher education in Russia 
Th e Republic of Tatarstan is a republic of the Russian 
Federation, located in the Volga Federal District in 
south central Russia. Its capital is the city of Kazan. Th e 
republic borders Kirov, Ulyanovsk, Samara, and Oren-
burg Oblasts, the Mari El, Udmurt, and Chuvash Re-
publics, and the Republic of Bashkortostan. Th e area 
of the republic is 68,000 square kilometres 
(26,000 square miles). In 2010 the population of Ta-
tarstan was 3,786,488. Th e Republic has strong cultur-
al ties with its eastern neighbour, the Republic of 
Bashkortostan. Th e state languages of the Republic of 
Tatarstan are Tatar and Russian.1 
Th e history of the formation of pharmacy education 
in Russia is closely associated with the organization of 
universities in educational centres across Russia. Th e 
fi rst Russian university was founded in Moscow in 1755 
upon an initiative of Mikhail Vasilyevich Lomonosov 
(1711-1765), a Russian polymath, scientist and writer, 
amongst whose discoveries were the atmosphere of Ve-
nus and the law of conservation of mass in chemical 
reactions. 
Th ereafter, six more universities were opened in 
Russian cities over the next eighty years. Th e next was 
in Dorpat (now Tartu in Estonia) in 1802, followed by 
Vilnyus (in Lithuania) in 1803. Th e following year uni-
versities were founded in Kazan (Tatarstan), and Khar-
kov (Ukraine), then in St. Petersburg (Russia) in 1819, 
and in Kiev (Ukraine) in 1834.
Th e idea of establishing a network of universities in 
Russia dates back to the reign of Catherine the Great 
(1729-1796), who was Empress of Russia from 1762 un-
til 1796. Th e organization of secondary and higher pub-
lic education in the Russian Empire began in the same 
period. By the end of Catherine’s reign some 223 edu-
cational institutions had been established in Russia. 
In accordance with the Charter of Educational In-
stitutions published on 5 November 1804 – eight years 
after Catherine’s death – educational districts and uni-
versities were initiated across Russia. A total of six dis-
tricts were formed, including the Kazan educational 
district. Th is covered a vast area; it included the terri-
tories covering the eastern provinces of the central zone 
of the European part of Russia; all its eastern provinces; 
the North Caucasus; and Western and Eastern Siberia. 
Th e Kazan educational district consisted of four-
teen regions, spread over a vast geographical area. 
Th ey extended from Kazan and Nizhniy Novgorod in 
the west; to Tambov, Penza, Caucasus (Stavropol) and 
Astrakhan in the south; and to Saratov, Orenburg, 
Simbirsk, Viatka, Perm, Tobolsk, Tomsk and Irkutsk 
in the east. Each region was under the control of a 
governor.
Universities were opened in all these towns to pro-
vide higher education in each district. Primary and sec-
ondary schools were provided in the towns of each re-
gion, along with gymnasiums and rural parish schools. 
In 1804 a Charter and Affi  rmative  Letter were 
granted to the Imperial Kazan University.2 According 
to the Charter four faculties were formed, one of which 
was a Division of Medical Sciences. Th is consisted of 
six departments, one of which was a Department of 
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Chemistry, Technology and Pharmacy. When this de-
partment was opened, twenty-eight sub-departments 
were created, each with its own professor. 
Th e rector and the deans were elected for a period 
of one year. According to the Charter, the Imperial Ka-
zan University had to have twenty-eight professors, 
twelve junior scientifi c assistants, three lecturers or 
teachers of the French, German, and Tatar languages, 
and three teachers of arts for entertainment and gym-
nastic exercises. In 1815 the number of students en-
rolled at the University was sixty-two. However, only 
three of these studied in the Medical Division. 
Figure 1. Imperial Kazan University 1866-1870. (Source: 
Photograph by G. F. Locke, in Tukhbatullina, RG. and 
Kuznetsova, AM. Kazan pharmacists. (Note 3) 2009: 33)
Th e start of pharmaceutical education in Russia 
Paragraph 73 of the Charter provided for the opening 
of a library, a physics laboratory, an astronomical ob-
servatory, a natural history study room, a botanical gar-
den, an anatomy theatre, institutes of clinical research, 
surgery and maieutics (philosophical methods), and a 
chemical laboratory. A pharmaceutical laboratory, a 
pharmacognostic study room, and a pharmacy were es-
tablished only by the late 1820s. Th e Medical Faculty 
was fi nally formed on 5 July 1814, and the teaching of 
pharmacy was introduced in the third year of the Med-
ical Faculty, whilst the total training period for phar-
macy was four years.3 
However, it should be noted that, according to ar-
chival documents, in the 1824-1825 academic year the 
schedule included no pharmaceutical disciplines; their 
teaching was revived only later. During the period be-
tween 1837 and 1858 the ‘Pharmaceutical Department’ 
was known as the ‘Department of Pharmacy’. 
In the period from 1837 to 1852, Karl Karlovich 
Klaus (also known as Karl Ernst Claus) worked at the 
Pharmaceutical Department of the Division of Medi-
cal Sciences at the Imperial Kazan University (Figure 
2). Klaus was an enthusiastic botanist and he took part 
Figure 2. K. K. Klaus 1796-1864 (Source: Tukhbatullina, 
RG. and Kuznetsova, AM. Kazan pharmacists. (Note 3) 
2009: 36)
in many expeditions.4 He was also the owner of ‘the 
best pharmacy in Kazan’. In 1837 he became a junior 
scientifi c assistant at the Department of Medical Herbs, 
Pharmacy and Medical Literature. In 1839 he was 
made a visiting professor of pharmacy, and in 1844 he 
was made a full professor of pharmacy. After 1854 he 
became an honorary member of the University. He was 
also head of the chemical laboratory at the university. 
Th e achievements of K.K. Klaus include the discovery 
of the chemical element ruthenium (Ruthenia trans-
lated into Russian means ‘Russia’). 
At diff erent time periods in the various departments 
of the university, a large number of distinguished Rus-
sian and international scientists have contributed to the 
teaching; at the Kazan University students listened to 
lectures by scientists who later became well-known 
around the world.
Th ese included L.L. Fogel and M.P. Sergeev, and 
other key fi gures who taught pharmacy subjects.
Alexander Mikhaylovich Butlerov (1828-1886) 
(Figure 3) was a Russian chemist, who was one of the 
principal creators of the theory of chemical structure. 
He was the fi rst to incorporate double bonds into struc-
tural formulas, and was the discoverer of hexamine and 
formaldehyde in 1859.5 
Nicholay Nikolaevich Zinin (1812-1880) (Figure 4) 
studied at the University of Kazan where he graduated 
in mathematics, but he started teaching chemistry in 
1835.5 To improve his skills he was sent to study in Eu-
rope for some time, which he did between 1838 and 
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(Figure 5). Vladimir Vasilievich Nikolaev graduated 
with honours from the Faculty of Medicine of Kazan 
University in 1895. Whilst still a student, he discov-
ered that the vagus nerve in the heart has two sen-
sory ganglia, the superior and inferior ganglia. In 
1905, as a supernumerary laboratory assistant at the 
Department of Pharmacology, as a doctor of medi-
cine and as a private assistant professor, Nikolaev was 
appointed to teach pharmacy. He lectured on alka-
loids and glycosides and conducted relevant practical 
training.
In 1919 he set up the Kazan Scientifi c Society of 
Pharmacists, and he remained its head until 1925. He 
co-authored and edited the State Pharmacopoeia: pub-
lications VII (1925) and VIII (1946). He also acted as 
executive editor to the journal Pharmacy and Pharma-
cology. Vladimir Nikolaev’s academic writings laid 
down the fundamental background for the pharmaceu-
tical industry in Russia, and made an important con-
tribution to assessing the quality of drugs. His works 
on medicinal plants laid the basis for scientifi c phyto-
therapeutic medicine.6
In 1863 the Pharmaceutical Department at the Im-
perial Kazan University was divided into two sub-de-
partments: the Department of Experimental Pharma-
cology, and the Department of Theoretical 
Pharmacology, which was later transformed into the 
Department of Pharmacognosy and Pharmacy. Accord-
ing to an Order of the Ministry of Public Education on 
17 February 1865, the Medical Faculty was divided into 
two divisions, designated as medical and pharmaceuti-
cal. Studying in the Pharmaceutical Department was 
mandatory for all medical students. 
Figure 3. A. M. Butlerov 1828-1886 (Source: Tukhbatul-
lina, RG. and Kuznetsova, AM. Kazan pharmacists. (Note 
3) 2009: 40)
Figure 4. N. N. Zinin 1812-1880 (Source: Tukhbatull-
ina, RG. and Kuznetsova, AM. Kazan pharmacists. (Note 
3) 2009: 40)
1841. He studied with Justus Liebig in Giessen, where 
he fi nished his research on benzoin condensation, which 
had been discovered by Liebig several years before. 
More recently V.V. Nikolaev has made an invalu-
able contribution to the development and growth of 
pharmaceutical education at the University of Kazan 
Figure 5. V. V. Nikolaev 1871-1950 (Source: Tukhbatul-
lina, RG., Galeeva, ZM. and Kuznetsova, AM. Phar-
macy: events, facts, people. (Note 6) 2010: 131)
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It should be noted that after 1813 scientists did not 
abandon the idea of creating a Medical Institute at the 
University, but the solution to this issue was delayed for 
many years. 
Pharmacy education in the twentieth century
Due to the poor attendance of Medical Division students 
at lectures in pharmacognosy and pharmacy in 1907, a 
proposal to re-organize pharmaceutical education with 
a three-year course of study was presented at the scien-
tifi c Council of the Faculty. Th is would involve the sep-
arate teaching of pharmaceutical disciplines to medical 
students and pharmacists, and would help address the 
problem of how to enable pharmacy to proceed in an in-
dependent direction. But this proposal was not approved, 
and teaching continued unaltered until 1915. 
However, during the First World War there was a 
shortage of specialists with the knowledge needed to 
develop the pharmaceutical industry in Russia. On 3 
September 1915, by the order of the Ministry of Public 
Education, chemical and pharmaceutical courses for 
the scientifi c training of chemists-pharmacists were 
opened at the Physical and Mathematical Faculty. In 
August 1919 the fi rst provincial Congress of Physicians 
was held in Kazan. During this meeting the important 
issue of the training of specialists for pharmaceutical 
institutions was discussed. 
Th e resolutions of the Congress indicated the neces-
sity of opening a separate School of Pharmacy at the 
Kazan State Medical University in the autumn of 1919. 
Th e Congress also resolved ‘to create a class of pharma-
cy workers for simple pharmacy work, for these reasons 
to open a special school in Kazan with a 2-year course 
for their training’. In 1921 the fi rst Kazan pharmaceu-
tical school was opened, but the issue of the organiza-
tion of the Faculty of Pharmacy at the University had 
not been resolved. In 2013 the Kazan Pharmaceutical 
School became part of the Kazan State Medical Uni-
versity. 
In 1930 the Medical Faculty of the Imperial Kazan 
University was transformed into the Kazan Medical 
Institute, and in 1994 the status of University was 
granted. Th e opening of the Faculty of Pharmacy at the 
Kazan State Medical Institute fi nally took place in 
1975. Currently the Faculty of Pharmacy is not the only 
centre for the education of pharmacists in the Republic 
of Tatarstan. Pharmacy education is also provided by 
the Institute of Fundamental Medicine and Biology 
within the Kazan Federal University (formerly the Im-
perial Kazan University).
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D O C U M E N T S  A N D  S O U R C E S
Major accessions to repositories in 2018 
relating to pharmacy and medicine
Th e National Archives, Kew, London
Th ere has been a slight delay in publishing data on 
major accessions to repositories in 2018, as Th e Nation-
al Archives (TNA) are moving to a new system which 
will facilitate input and analysis of collections informa-
tion. Th e 2018 accessions pages will be published short-
ly on the TNA website, but most of the data is already 
available through their online catalogue, Discovery.
Th is Documents and Sources note provides a digest 
of 2018 new accessions which may be of interest to 
pharmaceutical historians. However, researchers should 
be aware that not all of the data has been fi nally edited 
by TNA, and the list may not be entirely complete. Th e 
fi nal version will be available at http://www.national-
archives.gov.uk/accessions/.
Researchers should also be aware that, in addition 
to the ‘Pharmacy and Medicine’ digest, some material 
relevant to pharmaceutical chemistry and pharmaceu-
tical technology may be found in the ‘Science, Technol-
ogy, Engineering, and Mathematics Research’ digest. 
Major accessions to repositories in 2018 relating to 
pharmacy are as follows:
LOCAL
Bath Record Offi  ce
Professional medical recipe book with instructions for 
the creation of a large number of cures, owned by Ran-
dle Wilbraham Falconer (1816-1881), medical writer 
c.1775-1800 (1276).
City of Westminster Archives
Wallace Heaton (City Sale) Ltd, photographic chem-
ists: minute book of Board of Directors, share certifi -
cates, register of members 1918-1984 (2970).
Dorset History Centre
Weymouth Dispensary: committee minutes 1838-1862 
(D-3083).
Essex Record Offi  ce
Robert Edward Chatfi eld (b.1845), manufacturing chem-
ist: garden record book for Woodlands at Sewardstone and 
for a garden in Fulham 1884-1918 (D/DU 1510).
Sheffi  eld City Archives
Job Preston Ltd, chemists: records including account 
book 1887-1890s (X833).
Warwickshire County Record Offi  ce
Chapel End Chemist, Nuneaton: prescription book 
1951-1975 (CR 4972).
West Yorkshire Archive Service, Bradford
Harrison, Parkinson & Co, chemists: business records 
1833-1870 (WYB771).
West Yorkshire Archive Service, Leeds
Leeds and District Branch of the Royal Pharmaceutical 




Frederick William Boyer (fl . 1940-1949), pharmaceuti-
cal fi rm sales director: notebooks (12) containing a dai-
ly journal including illustrations 1940-1949 (Docu-
ments 27267).
Jersey Heritage Trust Archive
FG de Faye (Chemist) Ltd, Jersey: records including 
prescription registers and records relating to predeces-
sor businesses c.1870-1910 (JA/3294).
SPECIAL
Royal London Hospital Archives
Queen Elizabeth Hospital for Children, Shadwell: East 
London Hospital for Children and Dispensary for 
Women annual report 1931 (RLHT2018/155).
Royal London Hospital: Nursing Offi  ce records, in-
cluding ones relating to drug administration, the Salm-
on Report, pay, sterile supplies, nursing administration 
(RLHG2018/43).
Ligature Department album showing manufacture of 
catgut c.1940 (RLHT2018/48).
St Bartholomew’s Hospital Archives
Christopher Rice Pyle (fl . 1930-1932), clerk of works: 
drawings and blueprints for patented medical equip-
ment c.1930-1932 (SBHG2018/19).
St Bartholomew’s Hospital, London: pharmacopoeia 
and staff  photographs c.1900 (SBHG2018/02).
Wellcome Collection
‘Remarques curieuses sur divers sujets des prediction 
curieuse sur la fertilite et sterilite de chaque anne pen-
dant les siecles’, ms incl astrological treatise for predict-
ing harvest and a book of predominantly medical re-
ceipts and secrets c.1740 (MS.9290).
‘Elixir de longue vie’, ms, in French, medical receipt for 
an elixir for a long life c.1800. (MS.9289).
UNIVERSITY
Cambridge University Archives
Erasmus Darwin (1731-1802), physician, botanist and 
poet: memoirs of a journey to Edinburgh from Elston 
1753 (MS DAR 267/70).
Edinburgh University Library Special Collections
Persian manuscript on medicine, entitled Kitab al-‘ilal 
wa al-amrad 1877 (SC-Acc-2018-0034).
University College London Special Collections
David Colquhoun (b.1936), pharmacologist: papers re-
lating to work, research, correspondence and publica-
tions c.1970-2015 (COLQUHOUN).
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Drugs on the Page: Pharmacopoeias and 
Healing Knowledge in the Early Modern 
Atlantic World
Edited by Matthew James Crawford and Joseph M. Ga-
briel
Pittsburgh, Pa: University of Pittsburgh Press, 2019. 
Pp. ix + 374, Hardback, price $50.00. ISBN 
9780822945628.
Reviewed by Anthony C. Cartwright
D R U G S
on the
PA G E
P H A R M A C O P O E I A S
and
H E A L I N G  K N O W L E D G E
in the
E A R LY  M O D E R N  AT L A N T I C  WO R L D
Edited by Matthew James Crawford and Joseph M. Gabriel
From early times physicians and medical writers have 
sought to systematise knowledge about drugs and phar-
maceutical dosage forms, and the ways in which they 
are to be made. Texts appeared fi rstly as herbals and 
formularies - medical texts from individual authors. 
Th ey then started evolving into pharmacopoeias – rep-
resenting the collective knowledge of a medical tradi-
tion by a group of physicians and others in a particular 
society or culture.
One of the earliest texts was the Nuovo Receptario 
Fiorentino of 1498, a compilation of medicines ap-
proved by the College of Physicians of Florence. It was 
mainly drawn from the works of earlier Greek and Ar-
abic authorities such as Galen, Mesue, Niccholao and 
Avicenna. Th is book served as a model for regional and 
national pharmacopoeias in Europe and the Americas. 
Gradually the ‘offi  cial’ pharmacopoeias acquired the 
authority of a monarch or state, and were produced by 
an offi  cial body and made legally obligatory for physi-
cians and pharmacists.
Drugs on the Page comprises a series of twelve essays 
with an introduction by the editors, and an afterword 
by Pablo Gómez. It is based on presentations made at a 
workshop at the University of Madison-Wisconsin 
School of Pharmacy in April 2016. It is divided into 
four parts: ‘Pharmacopoeias and Textual Traditions’; 
‘Pharmacopoeias and Codifi cation of Knowledge’; 
‘Pharmacopoeias and the Construction of New Worlds’; 
and fi nally ‘Pharmacopoeias and the Emergence of the 
Nation’. Th ere are three essays in each part.
In the fi rst part Paula de Vos traces the development 
of texts in the Galenic tradition from their origins in 
ancient Greece and Rome through the medieval Arabic 
world to European formularies, and particularly those 
of Spain. Th e Spanish infl uence spread and the Phar-
macopoeia Matritensis developed by the Royal College 
of Apothecaries in Madrid was the standard pharma-
copoeia for the Spanish Empire. Royal decrees stipu-
lated that apothecaries throughout the Empire keep a 
copy in their premises.
Emily Beck, writing about the Nuovo Receptario 
Fiorentino, shows the changing focus of Italian medi-
cine from Arabic authorities to classical and Italian au-
thorities, and an adjustment of recipes to local practice. 
In 1739 the Pharmacopoeia Matritensis became offi  cial 
as an Imperial Pharmacopoeia throughout Spain’s ter-
ritories. In the third chapter, Matthew Crawford shows 
how locally available materials could be substituted for 
the offi  cial ones described in the text, and the adoption 
of imported American materials such as cinchona bark.
In the second part Justin Rivest explores the diff er-
ent types of medicines available in early modern France 
– offi  cinal, magistral and secret. His essay is illustrated 
using the example of orviétan, a secret remedy of the 
Contugi family, the formula for which was eventually 
published in eight European pharmacopoeias. Orviétan 
was promoted as a remedy for all poisons from snake 
venom to rabid dog bites, diseases like plague and 
smallpox, and also lesser conditions such as colic and 
digestive problems.
Timothy Walker in his essay explores the contribu-
tion of India’s and Brazil’s unique fl ora to the colonial 
Portuguese medical culture. In the last chapter in this 
section William Ryan considers how Sir Hans Sloane’s 
interest in New World nature infl uenced his work as 
editor of the Philosophical Transactions and the 1721 
London Pharmacopoeia.
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In the third part Benjamin Breen considers why Af-
rican herbal drugs, unlike those from the Americas, did 
not gain a signifi cant foothold in European medicine. 
Christopher Parsons then describes how the northern 
maidenhead fern, the Capillaire du Canada, became a 
pharmaceutical commodity in France as part of the 
network of pharmaceutical trade.
Kelly Wisecup’s essay, chapter 9, is reprinted from 
Early American Studies. It describes a herbal entitled 
Herbs & Roots produced in 1756 by Samson Occam, a 
Mohegan (a Native American tribe historically based 
in present-day Connecticut) which included remedies 
for disorders ranging from sore throat and broken legs 
to syphilis.
In the fi rst chapter of the fi nal part, Stuart Ander-
son describes the origins of the London, Edinburgh and 
Dublin Pharmacopoeias in the period 1618 to 1807, and 
how they were all developed against a background of 
political and religious turmoil. Th e books were written 
at a point in time when Galenic orthodoxy was clash-
ing with Paracelsus’s ideas about chemical therapeutics. 
National identity, medical politics and local traditions 
all played a part in shaping the pharmacopoeias.
Antoine Lentacker then describes the role of the 
French Codex Medicamentarius in codifying the usages 
of French pharmacy so that the composition of medic-
inal products would be legally defi ned. Lentacker 
makes the curious claim that the role of pharmacopoe-
ias shrank as the new drugs manufactured in factories 
displaced those made in pharmacies (in reality the 
pharmacopoeias have gone on to provide publicly avail-
able standards for manufactured medicines). Finally, in 
chapter 12, Joseph Gabriel reviews the role of Indian 
secrets and cures in North American medicine, and 
how some came to be incorporated as new drugs into 
the United States Pharmacopoeia.
A criticism of this book it is that quality is not men-
tioned when – as the various contributions show – so 
many drugs were imported in trade from across the 
world, and their quality was highly variable. Adulteration 
and counterfeiting of drugs occurred from the earliest 
times. Dioscorides, Pliny and Galen all used sense-per-
ceptions (organoleptic tests of appearance, smell, taste) 
to detect adulteration, together with defi ning the meth-
od of collection, part of the plant to be used and geo-
graphic origin. Flame tests and density were also used.
Modern pharmacopoeias are mainly concerned 
with defi ning the quality of drugs and manufactured 
dosage forms so that they are suitable for their intended 
medicinal purpose. Th e transition to a focus on the 
quality of medicines and its assessment in pharmaco-
poeias was a gradual one, but it had its origins in the 
early modern period. Tests for impurities and adultera-
tions were introduced into the 1836 London Pharmaco-
poeia, but earlier pharmacopoeias also concerned them-
selves with quality.
Th e impetus to produce pharmacopoeias was all 
about the attempts of medical elite groups to regulate 
the trade in medicinal substances and to defi ne how 
they are compounded into specifi c remedies. Th is book 
demonstrates that as European empires developed and 
expanded, the pharmacopoeias had to cope with the 
challenge of adapting to local colonial circumstances, 
and also with utilising new materia medica coming 
from Asia and the Americas.
Th e pharmacopoeias are all about creating order 
and structure to the available lists of medicines and dos-
age forms to create codifi ed knowledge. Th is book is an 
essential reference text for anyone interested in how 
pharmacopoeias developed in the early modern world, 
connecting diff erent geographies, cultures and tradi-
tions.
Th e references appear as endnotes collected in chap-
ter order at the end of the book, followed by a bibliog-
raphy of archival sources and further reading. Brief au-
tobiographical details on each of the authors of the 
essays are given at the end of the book.
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